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THE DETERMINATION OF NITROIMIDAZOLE 




A method was developed and validated for the determination of nitroimidazoles 
(NIs) including 2-hydroxymethyl-l-methyl-5-nitroimidazole (HMMNI), ipronidazole 
(IPZ), l-methyl-2-(2'-hydroxyisopropyl)-5-nitroimidazole (IPZ-OH), metronidazole 
(MNZ), l-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole (MNZ-OH), ronidazole 
(RNZ) and dimetridazole (DMZ) in fish and crustaceans by ultra performance liquid 
chromatography tandem mass spectrometry (UPLC-MS/MS). The compounds were 
extracted with acidic acetonitrile, followed by solid phase extraction (SPE) CI8 clean up 
and hexane washing. The validated method has a linear range from 0-50 ng/g in target 
representative species (tilapia, salmon and shrimp), with LOD from 0.07 - 1.0 ng/g and 
LOQ from 0.21 - 3.0 ng/g, depending on the analyte. Recoveries ranged from 87 to 121% 
for the analytes of interest. Method precision ranged from 6 to 26% RSD with HorRat 
values within typical limits of acceptability. The method successfully analyzed rainbow 
trout samples treated with MNZ in a depletion study under controlled conditions and is 
suitable for use in a regulatory monitoring program for residues of nitroimidazoles in 
seafood and aquacultured products. 
October 21, 2011 
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Chapter 1 - Introduction 
The aquaculture (fish farming) industry has experienced rapid growth during the 
last decade (Diaz-Cruz et al., 2003). Infectious diseases are a major concern in this 
industry because of potential negative impacts on production and the potential for disease 
impacts on wild populations (Johnston and Santillo, 2002). In natural systems there is a 
low prevalence of infection, but in the aquaculture industry where stresses lower 
resistance and stocking density facilitates transmission of disease, impacts of disease 
outbreaks can be severe. Disease management therefore depends on chemotherapeutic 
agents. Even though chemical usage is widespread in the aquaculture industry, chemical 
residues have received little attention. 
Nitroimidazoles are a group of veterinary drugs which have been used to treat 
infections in food producing animals (Huet et al., 2005). They are also used in the 
treatment of intestinal infections in fish caused by flagellates of the genus Hexamita, 
which has been associated with high mortality in young salmonids as well as aquarium 
fish and other marine species (Tojo and Santamarina, 1998). The most frequently used 
nitroimidazoles, dimetridazole (DMZ), ipronidazole (IPZ), metronidazole (MNZ) and 
ronidazole (RNZ), are suspected of being genotoxic, carcinogenic and mutagenic, as are 
their hydroxy metabolites which retain the original nitroimidazole ring (Huet et al, 2005). 
Their molecular structures can be seen in Figure 1.1. 
Health Canada scientists have reviewed the toxicity data submitted by 
manufacturers and assessed the risks and benefits of the use of nitroimidazoles in food 
producing animals (Health Canada, 2003). Due to concerns raised about the safety of 
residues found in food products from animals treated with the 5-nitroimidazole class of 
1 
drug, it was considered prudent to ban the sale of this class of drug for administration to 
food producing animals, the sale of treated animals for food use and the sale of food 
products derived from treated animals, although some of these drugs remain available for 
therapeutic use in humans. 
The Fish Program of the Canadian Food Inspection Agency (CFIA) has identified 
residue testing for the nitroimidazoles as a priority in their action plan with regard to EU 
requirements for fish exports (CFIA internal communication). The EU has required the 
CFIA to have a residue monitoring plan in place for nitroimidazoles in aquaculture 
products under Council Directive 96/23/EC (EC, 1996). To avoid trade disruptions, CFIA 
has committed to validating a method of analysis for nitroimidazoles in fish and fish 
products. The purpose of the validation studies is to establish method performance and 
demonstrate 'fitness for purpose' (CFIA Dartmouth Laboratory, SOP-DAR-CHE-001-00, 
2009), including meeting requirements for inclusion of the method within the "scope of 
accreditation" of the Dartmouth Laboratory under ISO-17025 (ISO, 2005) as 
administered by the Standards Council of Canada. 
To follow through with CFIA commitments and complete a thesis project, a two 
year study was initiated to satisfy the following objectives: 
• Critical assessment of existing information on analytical methods for 
nitroimidazole residues which may be applicable to fish tissues and on the 
distribution and depletion of nitroimidazole residues in fish. 
• Development and validation of a confirmatory method for the determination of 
nitroimidazole residues in tilapia, salmon and shrimp muscle tissues. 
2 
• Determination of stability of nitroimidazoles in solution, during sample 
processing/analysis and in fish tissue under typical conditions of storage. 
• Depletion study of nitroimidazoles in muscle tissue on fish species under 
controlled conditions. 
Based on these objectives a simple, rapid and robust method will be validated and used to 
monitor aquacultured products for the presence of nitroimidazole residues in a regulatory 
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Figure 1.1 Chemical structures of nitroimidazole compounds and metabolites. 
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Chapter 2 - Literature Review 
2.1 Background 
An antibiotic complex isolated from a strain of streptomyces in Japan in 1953 was 
identified as 2-nitroimidazole in 1955 (Anon., 1978). This discovery lead to the 
preparation and testing of the more readily accessible isomeric 5-nitroimidazoles. In 1957 
these isomers were found to be more active antiprotozoal agents than the natural product. 
The main properties of these compounds that account for their therapeutic success are 
their selective uptake by and cytotoxic action on anaerobic organisms (Lindmark and 
Muller, 1976). Their toxicity for aerobic microorganisms has been found to be low. 
Metronidazole (MNZ) was determined to give the best compromise between 
activity and toxicity and was introduced as Flagyl (Anon., 1978). It became well 
established as the first agent to be systematically effective against many protozoa. During 
the 1960s, many therapeutic claims were made for treatment of many conditions in 
humans. The most significant claim was for the treatment of acute ulcerative gingivitis. 
MNZ has also been useful in preventing post operative infection caused by susceptible 
anaerobes. It has been a difficult drug to improve upon (Voogd, 1981). Resistance among 
trichomonids, for example, has very rarely, if ever, been responsible for therapeutic 
failure. 
Research of nitroimidazoles has been concerned with important veterinary uses as 
well as applications in human medicine (Research Article, 1978). Dimetridazole (DMZ), 
which is more toxic than MNZ, was selected for treatment in animals (Voogd, 1981). 
Many other nitroimidazole compounds have been synthesized and investigated for 
therapeutic or prophylactic applications. Tinidazole, nimorazole and ornidazole are 
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applied as drugs in human medicine, while ronidazole (RNZ) and ipronidazole (IPZ) have 
veterinary applications. 
Several nitroimidazoles, including DMZ, IPZ, MNZ and RNZ, were reviewed in a 
report by the Joint Food and Agriculture Organization / World Health Organization 
(FAO/WHO) Expert Committee on Food Additives (WHO, 1989), which recommends 
international standards for permitted concentrations of food additives, contaminants and 
residues of approved veterinary drugs in foods to the Codex Alimentarius Commission 
(CAC). The committee noted that there was increasing concern by regulatory authorities 
regarding the presence of residues of nitroimidazoles in food. They encouraged industry 
groups and national authorities to generate the necessary toxicological and residue data 
for safety assessment. They stressed the importance of examining the possible hazard to 
human health arising from the ingestion of residues of antimicrobial agents administered 
to food producing animals. Due to the gaps in available data, the committee was unable to 
establish an Acceptable Daily Intake (ADI) for these compounds, so no Maximum 
Residue Limits (MRLs) have been established for nitroimidazoles in foods by the Codex 
Alimentarius Commission. 
DMZ, RNZ and MNZ are banned from use in food producing animals in the EU, 
US and China (Mottier et al., 2006). IPZ has never been authorized for use as a veterinary 
drug and is also considered a banned substance. The use of nitroimidazoles in food-
producing animals (including fish) has been banned in Canada under the Food and Drug 
Act and Regulations (Department of Justice Canada, 2008). 
2.2 Toxicity of Nitroimidazoles 
6 
The mutagenic action of nitroimidazoles against bacteria has been well 
documented for many years. The antimicrobial action of 5-nitroimidazoles is believed to 
be due to the metabolic reduction of the nitro group by microbial metabolism (Schmid 
and Schmid, 1999). A review by Voogd in 1981 showed that MNZ was the most 
investigated compound of the nitroimidazoles for mutagenicity and noted that MNZ was 
found to be mutagenic to bacteria. In a study by Voogd et al. (1974), DMZ was found to 
have similar activity to MNZ, but less than RNZ which even at low concentrations 
exerted a pronounced mutagenic effect against three types of bacteria. The activity of the 
hydroxy metabolite of MNZ has been shown to have approximately 65% of the activity of 
the parent drug on bacteria and the activity of MNZ was enhanced when combined with 
its hydroxy metabolite (Pendland et al., 1994). The reduction products of MNZ also cause 
DNA damage if the nitro group is reduced in the presence of DNA (Voogd, 1981). 
Studies have demonstrated that these drugs induce mutations even in bacteria resistant to 
their killing activity. 
The mutagenic effect of nitroimidazoles on mammals has been less clear. 
However, in one study serum levels attained in man after therapeutic treatment with MNZ 
were sufficient to cause mutagenic activity in bacteria (Voogd, 1981). Mutagenic activity 
to bacteria can also be demonstrated in the urine of human subjects after treatment 
(Conner et al., 1977). The activity detected in the urine was significantly higher than 
could be accounted for by the presence of the administered drug. Chromatographic 
analysis indicated the presence of a metabolite which was found to be ten times more 
mutagenic than MNZ. A much lower dose of MNZ was required in humans than mice for 
significant amounts of metabolite to be detected in the urine. The metabolite was reported 
7 
to represent 35-40% of the nitroimidazole excreted in urine of treated patients. These 
findings not only established concern for use of the parent compounds, but also the 
metabolites that are formed. 
In contrast, little or no mutagenic effect was shown on mammalian cells in vitro 
with MNZ (Voogd, 1981). When the potential toxicity of RNZ residues present in the 
tissues of food-producing animals was assessed, the data demonstrated that although RNZ 
is a potent mutagen, residues from it which may be present in the tissues of animals lack 
any mutagenic activity and are probably not hazardous to humans who consume them 
(Wilslocki et al, 1984). Reduced derivatives of DMZ were also shown to lack mutagenic 
activity. In other investigations, no teratological effects due to MNZ or most other 
nitroimidazoles have been observed (Elizondo et al., 1994). In a genotoxic study on 
human lymphocyte cells, MNZ did not induce changes in sister-chromatid exchanges 
(Voogd, 1981). 
Even though no mutagenic activity was observed in mammalian cells in vitro, 
reduction products are formed by microbes in the gut or by mammalian cells under 
anaerobic conditions. Acetamide is a metabolite generated from MNZ by microbes in the 
gut of mammals and is carcinogenic to rats if applied in high dosages. MNZ was found to 
be carcinogenic in mice and rats, and dimetridazole in rats. MNZ was found to induce 
lung tumors in mice and its metabolism is similar in mice to that in humans (Voogd et al., 
1974). It was concluded that long term effects on humans are not known and genetic 
damage cannot be excluded (Voogd, 1981). With the very mutagenic nitroimidazoles, 
serious genetic and carcinogenic effects are probable. Therefore, the recommendation was 
the prevention of unnecessary exposure of humans to these drugs. It was clear by 1981 
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that the data reviewed were beginning to cause serious concern about the safety of 
nitroimidazoles. The review paper by Voogd (1981), in particular, emphasized the 
importance of studying nitroimidazoles for their safety. 
Another study suggested that there are reduced nitroimidazoles which are 
responsible for toxicity to mammalian cells (Noss et al., 1988). The metabolites retaining 
the nitroimidazole ring were found to be carcinogenic and mutagenic in some species 
(Mottier et al., 2006). Nitroimidazoles have been shown to be differentially cytotoxic 
towards hypoxic mammalian cells (Silver et al., 1986). A dose-dependant reduction of the 
nitro group in animals and aerobic microorganisms can be caused by very high doses of 
5-nitroimidazoles. This explains the tumors found in laboratory animals exposed to high 
doses of nitroimidazole drugs (Schmid and Schmid, 1999). Research indicates that MNZ 
is considered to be mutagenic and cytotoxic in fish (Maher et al., 2008). However, it 
should not be assumed that therapeutic doses of all 5-nitrimidazoles pose a genotoxic 
hazard (Schmid and Schmid, 1999). 
Genotoxic activity of MNZ was evaluated in vitro (human lymphocyte cells) and 
in vivo (mouse bone marrow cells) by Mudrey et al (1994). A genotoxic effect indicated 
that MNZ is a direct mutagenic and chromosome damaging agent. It was recommended 
that the consumption of MNZ should be controlled in order to protect the public health 
from its mutagenic/carcinogenic risk. Genotoxic effects of MNZ were evaluated in the 
hamster embryo and it was concluded that MNZ is capable of transmission of potential 
genotoxic effects to the fetus (Garry and Nelson, 1987). It was apparent that MNZ needs 
further evaluation for potential adverse reproductive outcomes. In reproductive studies, 
many 5-nitroimidazole compounds are reported to inhibit spermatogenesis and cause 
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infertility (McCIain and Downing, 1988). Data from studies with nitroimidazoles suggest 
that these agents may be genotoxic as they induced chromosomal aberrations in human 
lymphocytes in vitro and in vivo at high doses (Committee for Veterinary Medicinal 
Products, 2008) 
The most recent review of the toxicology of MNZ found in the literature search, 
published in 1994, discussed the major findings relating to biotransformation, 
genotoxicity and carcinogenicity of MNZ (Dobias et al.). The paper concluded that the 
present data available are insufficient to permit an accurate evaluation of the complete 
risk posed by MNZ to human health. There are many papers concerning MNZ 
genotoxicity, but further definitive studies are required before the real risks of MNZ on 
human health can be ascertained. MNZ is a chemical agent of great concern based on its 
toxicity and has been identified as a priority for future research, including analytical 
determination (Johnston and Santillo, 2002). 
In the proceedings of a meeting of an expert group organized by the aquaculture 
authority, Government of India, it was stressed that the unscientific use of antibiotics, 
including nitroimidazoles, can have adverse impacts on human health and also the 
environment (The Aquaculture Authority, 2002). Fish farming is an important source of 
drugs in the environment. Even though it has been estimated that around 70% of the drugs 
administered in aquaculture are released into the environment, very little information is 
available about the fate and the potential effects of these drugs in the environment (Diaz-
Cruz et al., 2003). In recent years it has become clear that the use and disposal of 
medicinal substances may have adverse effects on the environment (Lansky and Halling-
Sorenson, 1987). The acute toxicity of MNZ was tested on freshwater and marine 
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organisms. The study demonstrated the potential ecotoxic effect of MNZ, suggesting the 
need for further investigations of the environmental effects resulting from exposure to 
medicinal substances. 
The literature reviewed that is related to the toxicity and carcinogenicity of 
nitroimidazoles in bacteria, animals and humans and the potential impact on the 
environment emphasizes the need to monitor the use of these drugs in food producing 
animals to prevent unnecessary exposure for consumers. The importance of monitoring 
these drugs is reinforced by the contradictions and unknowns of the risks of 
nitroimidazoles in the reported studies. A great deal of unknown effects appears to be 
related to the oxidative and reductive products involved in the metabolism of 
nitroimidazoles. For this reason, metabolites as well as parent compounds need to be 
analyzed. 
2.3 Stability of Nitroimidazoles 
To provide an effective program for the control of nitroimidazole use in food-
producing animals and their products (including fish and fish products) the conditions 
under which sampling takes place are of utmost importance (Polzer and Gowik, 2005). 
Factors such as matrix, temperature conditions and homogeneity of the sample have to be 
taken into account. These conditions can contribute significantly to the ability to detect 
the illicit use of substances. The investigation of information on stability of 
nitroimidazoles is important for the accuracy of results. It defines the requirements for 
storage of standards and also for the shipment and storage of laboratory samples. 
The literature was assessed for existing information on the stability of 
nitroimidazoles in both biological matrices and solution. A working paper prepared by 
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scientists in the European Union notes that nitroimidazole residues are unstable in animal 
muscle, although no supporting data were provided (EU, 2006). In studies with pig 
muscle and plasma, good stability of both the DMZ and its metabolite HMMNI were 
shown for several days at 4°C and several months at -30°C (Carignan et al., 1988a). 
Conversely, thermal stress was shown to have an extreme impact on the concentration of 
nitroimidazoles in turkey muscle (Polzer and Gowik, 2005). Immediate freezing of 
muscle tissue samples after sample collection is essential for effective residue control. 
Stability studies of with DMZ, MNZ, RNZ and IPZ in treated turkeys demonstrated that 
nitroimidazoles are not stable in muscle or liver at room temperature and decelerated 
degradation is seen at 4°C (Polzer et al., 2004). Plasma and retina samples are stable 
under the same storage conditions and storage at -24°C considerably slows down 
degradation of analytes. 
In a slightly different stability study, standards were mixed with plasma, rather 
than using incurred samples (Gibson et al., 1994). These were stored at -20°C and showed 
no loss of imidazole compounds (MNZ and its hydroxyl and acid metabolite and TNZ) 
after storage for as long as 2 weeks. 
Another study was found to be particularly interesting since nitroimidazole 
residues are normally tested on raw tissue, but we normally eat our food after it is cooked 
(Rose et al., 1999). This study found that there is little evidence of any instability of 
DMZ, RNZ and their metabolite in chicken during normal cooking. In model aqueous and 
lipid solutions, DMZ and its 2-hydroxy metabolite, were relatively stable for times and 
temperatures normally encountered during cooking. RNZ in hot aqueous solutions was 
converted to the 2-hydroxy metabolite. This reinforces the idea that food for human 
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consumption should be tested for nitroimidazoles residues as they are not destroyed 
during the cooking process. 
Stability of standards varied depending on the solvent used and storage 
temperature. Stock standards of DMZ and deuterated DMZ in methanol were stable for at 
least 3 months when stored at 4°C in amber colored vials, while dilute standard solutions 
prepared from stock solution in methanol were stable for at least a month when stored at 
4°C (Cannavan and Kennedy, 1997). RNZ, MNZ and DMZ stock solutions were prepared 
in 50/50 v/v water/acetonitrile and stored at 4°C for a maximum of 1 month (Daeseleire et 
al., 2000). Another study showed that DMZ stock standard in acetonitrile-water (50/50 
v/v) was stable for at least 8 months at -18°C (Mortier, 2005a). Standards of HMMNI (2-
hydroxymethyl-l-methyl-5-nitroimidazole) and IPZ hydroxyl metabolite, IPZ-OH, 
prepared in ethyl acetate are stable for at least one year if refrigerated (United States 
Department of Agricultural Food Safety and Inspection Service, 2005). Stability for 1 
year at 4°C was also seen in stock standards of RNZ, MNZ, IPZ, HMMNI, IPZ-OH and 
MNZ-OH (MNZ hydroxyl metabolite) in methanol (Fraselle et al., 2007). Intermediate 
and working standards from stock made up in 0.1% acetic acid/acetonitrile (93:7) were 
stable at 4°C for 6 months. Stock standard solutions of MNZ, DMZ, RNZ and TNZ in 
methanol stored in the dark at -18°C can be used for 2 months. The working standard 
should be prepared daily (Zhou et al., 2007). Lastly, two studies stored various 
nitroimidazole stock standards made up in methanol in dark glass bottles at -20°C for 6 
months. The intermediate standard made up from stock with MeOH was stable for 2 
months at 4°C in the dark and the working standard in methanol was good for 2 weeks in 
one study (Xia et al., 2008) and for 2 months in the other (Xia et al., 2006b). 
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The information on the stability of different nitroimidazoles in different solvents 
at various temperatures is useful. Although because of the variability reported in different 
studies, stability studies were repeated using conditions specific to the thesis project. 
Unfortunately, no information on the stability of these drugs in fish tissue was in any of 
the literature. Therefore, it was considered important to study the stability of 
nitroimidazoles in fish tissue under typical conditions of storage. Results of studies using 
muscle tissues of different species may be used as a guideline. Also, several of the 
methods recommend storage of standards in amber glassware or in the dark. However, 
there was no information specifically stating that the nitroimidazoles are susceptible to 
degradation by light with the exception of one paper. Hurtaud-Pessel et al. (2000) stated 
that nitroimidazoles are very light sensitive and therefore it is essential to protect the 
solutions and the extracts from light. This variable required further investigation. 
In a recent paper by Xia et al (2009), stability of nitroimidazoles was determined 
in solvent, in matrix (swine kidney) and in final sample extract. For stability in solvent, 
stock solutions were tested monthly by injection of freshly prepared working solutions. 
Six kidney samples were fortified with nitroimidazoles (5 |ig kg " ), among which three 
were analyzed immediately and the others were stored at -20°C for four weeks before 
analysis to assess stability in matrix. To study the stability in extract, fortified samples 
were analyzed, then the final extracts were stored at -20°C for 7 days, thawed at room 
temperature, then analyzed again. There was no significant difference (p> 0.05) observed 
under the storage treatments of nitroimidazoles in solvent, matrix or final sample extract. 
A similar approach to this was followed to determine stability of nitroimidazoles in the 
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thesis project to better define requirements for storage of nitroimidazole standards and for 
shipment and storage of laboratory samples offish species. 
2.4 Depletion and Distribution of Nitroimidazoles 
Depletion studies can be useful in determining the probable illegal treatment 
regimens with nitroimidazoles which may lead to detectable residues. Such studies were 
previously used before the ban of nitroimidazoles to determine withdrawal times required 
for residues in foods to be considered safe. During medication with DMZ, the mean 
concentration of the drug and its major metabolite depend on the animal species and the 
tissue (Carignan et al., 1988a). In pork muscle, the total concentration of drug and 
metabolites bearing the nitro group declines rapidly within hours after the medicated feed 
is withdrawn; within 72 hours it is below the limit of detection. A study to monitor the 
elimination of DMZ and its major metabolite in swine plasma and tissue showed very 
little HMMNI and no DMZ in the liver after 2 hours (h) of withdrawal (Carignan et al., 
1988b). No drug or metabolite could be detected at 49 h in any of the tissues, including 
muscle and kidney. Most values for both substances found in muscle were close to those 
in plasma. The muscle of swine given DMZ in feed for 14 days contained no detectable 
levels of HMMNI at 12 h withdrawal time (Newkirk et al., 1990). DMZ, RNZ and 
HMMNI are all rapidly eliminated from poultry muscle tissue, with no detectable 
residues present after 5 days following the withdrawal period (Rose et al., 1999). In 
turkeys treated with DMZ, the analyte and hydroxy metabolites could be detected for a 
longer period of time in plasma and retina than in muscle and liver (Polzer et al., 2004). 
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After a withdrawal period of 5 days, DMZ and its metabolites can still be found in the 
muscle and liver. 
DMZ is absorbed from the gastrointestinal tract in treated turkeys. About 88% of 
the administered dose is eliminated from turkeys within 3 days, whereas about 76% is 
eliminated from pigs within 7 days (Committee for Veterinary Medicinal Products, 2008). 
In depletion studies on turkeys and pigs, tissue-bound residues were evaluated using 
radiolabelled DMZ. About 50% of the total radioactivity was not extracted. In another 
depletion study summarized in the CVMP report, DMZ and its metabolite could be 
detected in skin/fat of pigs until 9 days and in turkeys until 12 days after treatment. 
Depletion rates could potentially be much longer if bound residues are not 
extracted (Health Canada, 2003). Bound residues are a concern for the determination of 
nitroimidazole residues. There are insufficient data on the depletion rate of bound 
residues of the 5-ntiroimidazole drugs to enable appropriate withdrawal periods. 
Nitroimidazole residues in eggs are the least related to the thesis project; however 
it was decided to include the information in case it may be useful. Nitroimidazoles are 
rapidly incorporated into eggs of laying hens, with residues detected 1 day after 
commencement of treatment (Rose et al., 1999). Depletion studies have shown that after 
one dose, residues are present for up to 8 days. After a single oral dose of IPZ, RNZ and 
DMZ to laying hens, residues of parent compound and/or the hydroxylated metabolites 
could be detected in eggs 5-8 days after dosing (Aerts et al., 1989). These findings are 
consistent with those reported for another veterinary drug, lasalocid, where it was 
demonstrated that exposure to the drug results in deposition of residues in eggs during 
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their formation, so that such residues are seen in eggs produced for up to 10 days after 
removal of the exposure to the drug (Kennedy, Hughes & Blanchflower, 1998). 
Information on distribution of residues identifies appropriate tissues for analysis. 
Some distribution information for nitroimidazoles has been included with the depletion 
studies, such as the mention of bound residues. More information on distribution is 
included in the following. In turkeys treated with DMZ, MNZ, RNZ and IPZ, analytes 
were found to be present in considerably higher amounts in plasma and retina compared 
to muscle and liver (Polzer et al., 2004). Nitroimidazoles in incurred muscle samples 
showed a considerable inhomogeneity in their distribution (Polzer and Gowak, 2005). An 
inhomogeneous distribution of IPZ and RNZ and their metabolites in turkey muscle 
samples is seen irregardless of sampling procedures. For effective residue control, 
lyophilization is recommended to achieve homogeneous muscle tissue samples. After 
administration of feed containing DMZ to laying hens, residues will appear in both egg 
white and yolk (Kan and Petz, 2000). Deposition of the drug in egg white and yolk 
requires intestinal absorption and transport via blood (plasma). For both DMZ and its 
metabolite, much higher concentrations are found in the albumin than the yolk (Mortier et 
al., 2005b). 
Information on the depletion and distribution of MNZ and MNZ-OH in trout was 
reported by Sorensen and Hansen (2000). Trout were given feed containing MNZ in an 
aquaculture pilot plant. Residues of MNZ and MNZ-OH were detected in muscle and skin 
tissues shortly after the administration period, but not 3 weeks later. The concentration 
levels in muscle and skin tissue were not significantly different. A MNZ depletion study 
was also done on tilapia. Farm raised adult tilapia were treated with MNZ for 5 days 
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followed by a 5 day withdrawal period (Maher et al, 2008). Relatively high levels of 
MNZ were present in the muscles during dosing; these levels decreased during 
withdrawal, however were still present at the end of the 5 day withdrawal period. This 
was the only information found on this topic for fish. Both of these fish depletion studies 
were taken into consideration when planning the study as part of the thesis project. 
2.5 Metabolism of Nitroimidazoles 
The 5-nitroimidazoles are rapidly metabolized with the main metabolite of DMZ, 
IPZ, and MNZ resulting from the oxidation of the side chain in the C-2 position of the 
imidazole ring (Rose et a l , 1999). RNZ has a different degradation pathway and shows 
only a minor metabolite containing the imidazole ring, identical to that of DMZ. The 
hydroxylated derivative of DMZ has been recognized by the 34l Joint FAO/WHO Expert 
Committee on Food Additives (JECFA) as the major metabolite in tissues (WHO, 1989). 
This assessment was also used by the Committee for Veterinary Medicinal Products 
(CVMP, 2008). From measurements of the parent drug and the corresponding main 
hydroxyl-metabolite in various incurred materials from turkeys, it can be concluded that 
HMMNI should be chosen as the target analyte to prove a treatment with DMZ and the 
metabolite IPZ-OH used as proof for IPZ, while the parent drug is to be preferred for 
RNZ and MNZ (Polzer et al., 2004). In trout treated with MNZ, the fraction of the 
metabolite to the parent was found to be low, leaving the parent drug the analyte of 
interest (Mottier et al., 2006). Sorensen and Hansen (2000) had previously reported 
similar findings in trout treated with MNZ. They found the fraction of MNZ-OH to MNZ 
was less than 2% on the first day after the administration period. This ratio of MNZ-OH 
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to MNZ was also observed by Maher et al (2008) in tilapia with incurred residues 
resulting from treatment with MNZ. 
During the plateau period for drug residues in eggs for DMZ and its metabolite, 
the metabolite/parent compound ratio equals 2.6 +- 0.2. This clearly indicates that the 
hydroxyl metabolite must be included when performing residue analysis for DMZ 
(Mortier et al, 2005b). In depletion studies of laying hens DMZ and IPZ were extensively 
metabolized to hydroxylated nitroimidazole metabolites; RNZ was excreted mainly as the 
parent compound (Aerts et al., 1991). From these studies of varying matrices it appears 
the parent drug is the target analyte for RNZ and MNZ residue monitoring. However, the 
metabolites HMMNI and IPZ-OH for DMZ and IPZ, respectively, are the target analytes. 
This was important information to consider for the thesis project and emphasizes the need 
to not only analyse for parent compounds, but to consider metabolites as well. 
2.6 Methodology for the Determination of Nitroimidazoles 
Methodologies for the determination of nitroimidazoles have been described for 
some time. In reviewing the literature on nitroimidazoles, the topic of methodologies was 
the most important for the project. JECFA reaffirmed the importance of reliable analytical 
methods in the regulatory control of veterinary drug residues in food-producing animals 
(WHO, 1989). The committee strongly recommended that increased efforts should be 
made to validate such methods and to obtain validation data. Few such data were 
available for consideration at the meeting. 
Validation data provide information to determine if a method is fit for purpose 
(CFIA Dartmouth Lab, SOP-DAR-CHE-001-00, 2009). In order for a method to be fit for 
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purpose certain performance characteristics must be evaluated and met. The requirements 
for a quantitative method include the following parameters: analytical range; linearity; 
selectivity; matrix effects; limit of detection (LOD) and limit of quantification (LOQ); 
accuracy; stability of analyte in standard solution, matrix and extract; repeatability of 
detection system and method; intermediate precision; decision limit (CCa) and detection 
capability (CCP); measurement uncertainty (MU) and ruggedness. The method to be 
validated is tested, modified and optimized as required to obtain the desired values for the 
parameters listed. 
When new methods are developed, method selection, development, modification 
and adaptation (including characteristics of the analytical range, linearity, selectivity, 
initial demonstration of recovery and precision and preliminary LOD/LOQ) must be 
completed prior to validation activities. Method ruggedness must be determined and 
critical control points identified before method validation commences. Analytical 
methods selected for validation and implemented for regulatory use may be chosen from 
previously published methods in the scientific literature, methods supplied by technical 
organizations, drug or equipment manufacturers or from "in-house" methods 
development, but in all cases optimized parameter data must be demonstrated prior to 
routine use of the method. 
To ensure human food safety, the development and improvement of residue 
analysis is an important task (Xia et al., 2007). Due to banning of the use of 
nitroimidazoles in food-producing animals, residue monitoring requires the sophisticated 
analytical techniques of gas chromatography (GC) or liquid chromatography (LC) 
coupled to mass spectrometry (MS) to provide confirmation of residue identity (Huet et 
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al., 2005). Owing to its high specificity and sensitivity, MS is well suited for confirming 
nitroimidazoles. LC coupled with MS or tandem MS (MS-MS) has become the most 
powerful approach for determining antibiotic residues in food (Xia et al., 2008). 
The less selective methods such as GC coupled with nitrogen-phosphorus 
detection (NPD) or LC coupled with fluorescence detection (FLD) can be useful for 
preliminary screening of samples for nitroimidazole residues, followed by the use of a 
confirmatory method for non-compliant samples (Thompson et al., 2008). The European 
Commission considers that a confirmatory method "means methods that provide full or 
complementary information enabling the substance to be unequivocally identified and if 
necessary quantified at the level of interest" (European Commission, 2002). 
Another important aspect of method development is investigating solvent 
extraction of the homogenized tissue followed by liquid partitioning and /or a solid phase 
extraction (SPE) clean up step. Tissue samples contain many diverse compounds in 
addition to possible traces of target analytes (Maher et al., 2008). It is very important to 
extract as much as possible of the target analytes and also to exclude interfering 
substances present in biological matrices. The majority of current methods employ a SPE 
step in order to purify the extract (Cronley et al., 2009). Extraction and clean up 
procedures selected from the literature were therefore identified to be evaluated and 
modified, as necessary, to determine the most appropriate procedures. 
2.6.1 Methodology Using Gas Chromatography 
In reviewing analytical methods for the determination of nitroimidazoles, GC 
methods predated and accounted for much fewer methods compared to LC. GC is now 
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less popular due to the required derivatization step to create volatile analytes. The 
derivatization step also results in the same derivatization product from RNZ and HMMNI 
(Wang, 2001). Most GC methods have been replaced by LC-MS due to lack of 
requirement for derivatization, applicability to parent compounds and metabolites, 
excellent detection capabilities and the potential to combine multiple classes of 
compounds in a single method. However, even though LC is the preferred technique for 
analysis of drug residues, it is not available in all labs. Two of the GC methods found are 
used in surveillance programs in other countries (Wang, 2001; Ho et al., 2005). It is 
important to know how other countries are monitoring these residues. In the first paper a 
method is developed and described for the determination of DMZ, RNZ and MNZ in 
chicken meat by GC-NPD. The author concludes the method is suitable for statutory 
residue testing and is used as a quick screening method in the National Residue 
Surveillance Plan in China. The other paper describes a method for the determination of 
DMZ and MNZ in poultry muscle and liver, and porcine liver and kidney by GC-MS. The 
method provides the means for fast turn around time and high sample throughput. The 
method was adopted for use in food surveillance programs in the Hong Kong 
Administrative Region. 
Another GC-MS method reviewed presented a method that is well suited as a 
screening method for the surveillance of DMZ, RNZ, MNZ, IPZ and their corresponding 
metabolites in turkey and swine muscle (Polzer and Gowik, 2001). Furthermore, DMZ, 
RNZ and MNZ in muscle samples of turkey and swine can be confirmed by this method. 
An earlier publication described the determination of HMMNI in swine muscle by GC 
electron capture detector (ECD) (Newkirk et al., 1990). This method evaluated the SPE 
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clean up step and conducted recovery studies on the overall procedure as well as at 
various stages of the procedure. Single compound methods were widely used in the 1980s 
and 90s, before many were replaced by LC and LC/MS multi-nitroimidazole methods. 
LC-MS is the preferred method for the thesis work as it is readily available in the 
laboratory. Other aspects of these papers may however be useful, such as the extraction 
and clean up procedures. 
2.6.2 Other Methodology 
Other methodologies include those that do not require sophisticated and expensive 
instrumentation. These methods can be useful as screening methods followed by a 
confirmatory method for positive samples. Non-instrumental screening methods are not 
the focus of the thesis project, but they can play a role in a regulatory environment. As 
with other screening methods, the extraction procedures may be useful for incorporation 
into more advanced procedures. 
The least impressive method was a high performance thin-layer chromatographic 
method for the fluorescence detection of DMZ, RNZ and HMMNI in pork and poultry 
tissue (Gaugain and Abjean, 1996). The paper concludes that the validation results prove 
the reliability of the method. However, the detection limits are subjective because the 
detection is visual. It is not apparent how a method that relies only on subjective visual 
detection can be reliable, as other researchers have noted variability of results recorded by 
different observers (Stead et al, 2005; Ashwin et al, 2009). In another method an antibody 
was generated that could bind MNZ (Huet et al., 2004). A direct competitive enzyme-
linked immunosorbent assay (cELISA) was used to characterize binding of this antibody 
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to a number of nitroimidazole drugs. The development and validation of an immunoassay 
for determining five nitroimidazoles in chicken muscle and egg, based on an antibody 
capable of broad spectrum compound recognition, was reported. Although unfamiliar 
with these methods, it is interesting work. 
The final two methods involve the use of an optical biosensor. The aim of the first 
paper was to develop a biosensor assay to detect a broad range of nitroimidazoles in 
chicken muscle (Connelly et al., 2007). The assay was developed and produced in a 
prototype kit format. Data generated from a multi-laboratory trial provided evidence the 
kit was easy to use and suitably sensitive to fulfill the standards required by international 
legislation. In the second study an optical biosensor screening assay was developed for 
the detection of nitroimidazoles in porcine, bovine and ovine kidney tissue (Thompson et 
al., 2008). It was further adapted to include avian liver, serum and eggs and bovine milk. 
The authors conclude that this method is capable of detecting low concentrations of a 
range of nitroimidazoles and their metabolites. It is used in labs as an initial screening 
program followed by confirmatory analysis for potentially non-compliant samples. These 
methods appear to be quick, inexpensive and apply to a wide range of species and 
matrices. Although they are not relevant to the current research, they may warrant 
investigation at a later time. 
2.6.3 Methodology Using Liquid Chromatography 
Of all the methods described in the literature, liquid chromatography is the current 
method of choice. Nitroimidazole residues have been determined in many different 
matrices using this technique. Honey, water and milk are probably the least similar 
matrices to fish, however, the methods are still worth reviewing in relation to the project. 
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The extraction procedures for these matrices are most likely not applicable, but the 
instrumentation parameters may be. 
Two methods were found for the determination of nitroimidazoles in water 
(Capitan-Vallvay et al., 2002 and Tamtam et al, 2009). The first method successfully 
determined MNZ, DMZ, IPZ, RNZ and the metabolite HMMNI in water samples using 
LC-MS with electrospray ionization (ESI) following clean up with SPE. SPE is a widely 
used preparation technique in the determination of pharmaceutical compounds. The other 
method was an ultra performance LC-ESI tandem mass spectrometry method (UPLC-
MS-MS) method for the determination of 17 antibiotics in natural waters, one of which 
was from the nitroimidazole group (ornidazole). Significant progress has been made in 
recent years in chromatographic analysis by the introduction of UPLC which provides 
higher peak capacity, greater resolution, lower detection limits and higher speed of 
analysis. Although the analysis of water used in farming fish would be interesting, it is 
not part of the proposed project. However, the conditions for LC-ESI-MS-MS were 
considered in the initial method development process. 
The method developed and validated for the determination of veterinary drugs 
including nitroimidazoles in milk was based on ultra performance LC-time of flight-MS 
or UPLC-ToF-MS (Stolker, 2008). As previously mentioned, the technique of UPLC 
provides improved resolution while shortening run times. The selectivity of ToF should 
be greater than that of MS-MS due to higher resolution, but detection limits are usually 
higher. ToF instrumentation was not available for research purposes on the thesis project, 
but the information on UPLC separation was useful, particularly for demonstrating the 
selectivity and speed of analysis using this chromatographic separation technique. 
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A simple and sensitive method was developed for the determination of MNZ, 
DMZ, RNZ, tinidazole (TNZ) and HMMNI residues in honey by LC-UV (Zhou et al., 
2007). While the accuracy and precision of this method meet the requirements for 
monitoring drug residues in honey, it was considered that the extraction conditions used 
were considered unlikely to be applicable to fish. In addition, LC-UV is not a 
confirmatory method. 
Plasma, urine and eggs are also quite dissimilar to fish tissue; nevertheless several 
LC methods developed for these matrices were evaluated. Plasma has been determined to 
be the preferred target matrix for nitroimidazole residue control in some countries since 
the residues are homogeneously distributed and more stable compared with muscle tissue 
(Fraselle et al., 2007). A method using confirmatory analysis by LC coupled to 
atmospheric pressure chemical ionisation MS (LC-APCI-MS-MS) was developed and 
validated. LC-MS-MS was shown to be a good choice for the identification and 
quantification of nitroimidazoles in plasma with the exception of IPZ and IPZ-OH for 
which identification only was possible due lack of specifity. A reliable and sensitive 
method was also developed and validated for the determination of RNZ, MNZ, DMZ and 
HMMNI in swine urine by LC-MS-MS in positive-ion ESI mode (Xia et al., 2006b). The 
LC-MS-MS conditions in positive-ion ESI and APCI mode were helpful in planning 
analytical approaches to be evaluated in the project work. 
Some LC methods have been described which are specifically for eggs, while 
others are for application to eggs and other matrices, such as poultry and swine tissues. In 
a fast, sensitive and very selective HPLC-MS-MS method for the detection of RNZ, MNZ 
and DMZ in eggs, the extract was filtered and directly injected into the LC-MS-MS 
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system (Daeseleire et al., 2000). Tuning of the LC-MS-MS instrument was performed 
with compound solutions in positive ESI mode. Fish tissue was considered likely to 
contain too many potential interferences for such a simple extraction procedure with no 
clean up step. Tuning of the LC-MS-MS in ESI (+) mode is useful. In another LC-ESI-
MS-MS based method in eggs for the determination of nitroimidazoles, a molecular 
imprinted polymer (MIP) was synthesized and tested to extract four nitroimidazoles and 
three of their metabolites from egg powder samples (Mohamed et al., 2008). The use of 
MIP sorbents resulted in selective binding of the targeted analytes while removing 
interferences. MIP-SPE was also evaluated in another report for the extraction of 
nitroimidazole compounds from milk and egg samples and analyzed by LC-MS (Shimelis 
et al, 2009). Highly reproducible recoveries were observed using the MIP technology. 
MIP-SPE may warrant further investigation for use with fish tissue when these products 
are readily commercially available. Two more methods for eggs using LC-MS-MS for the 
determination of DMZ were reviewed (Mortier et al., 2003; Mortier et al., 2005). The 
method in the article from 2005 was also used for determination of DMZ in feed. This 
method was useful to determine levels in medicated feed for depletion studies. 
The latest LC method for eggs, which was also for the determination of the 
highest number of nitroimidazole compounds, was by Cronley et al (2009). A rapid, 
confirmatory method was developed for the determination of 11 nitroimidazoles in egg 
using LC MS-MS. Egg samples were extracted with acetonitrile and NaCl added to 
remove contaminants. This was followed by a wash step with hexane. 
A number of papers described LC methods which were for both eggs and animal 
tissue including turkey, poultry and swine. The first paper described a simple and rapid 
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method for the determination of DMZ in poultry meat and liver and in eggs by LC-MS 
after solvent extraction and SPE clean up (Cannavan and Kennedy, 1997). This method 
can be used to monitor residues caused by contaminated feed or illegal use. It provides 
mass-related data which are desirable for confirmatory methods. Since this method 
involves confirmatory MS it was taken into consideration for the project work. The 
extraction for poultry tissue is also more similar to fish tissue. Another paper describes 
the development of an HPLC-UV screening method for the presence of nitromidazoles as 
well as a confirmatory HPLC-APCI-MS method (Sams et al., 1998). The HPLC-UV 
method was validated on egg and chicken muscle samples and the HPLC-APCI-MS was 
validated on egg samples. Both of these procedures have been used for the analysis of 
samples as part of UK surveillance programs. The fact that this method involves a 
confirmatory method that is being used in the UK is helpful. 
In another method which reported the determination of RNZ, MNZ, DMZ and 
HMMNI in poultry and swine muscle and eggs by LC-ESI-MS-MS, samples were 
extracted, filtered and the extract was directly injected into the LC-ESI-MS-MS system 
(Xia et al., 2006a). While it would be beneficial if this method could be applied to fish 
tissue, it is unlikely that fish tissue could be extracted and run without a cleanup step. 
Interference, in fact, was reported for the analysis of the muscle samples in this method. 
The problem was overcome by addition of NaCl, which could be attempted in fish tissue. 
The addition of NaCl with extraction solvent also allowed for greater removal of 
impurities and produced cleaner samples for analysis with egg samples (Cronley et al, 
2009). Shao et al (2009) reported an additional method which directly injected sample 
extracts into a UPLC-ESI-MS-MS system. This method was developed for determining 
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14 coccidiostats (including RNZ, MNZ and DMZ) in eggs and chicken. It was reported 
that a purification step was not carried out due to poor recoveries of some analytes. This 
is contrary to what is usually reported by most papers. 
One paper focused on clean up procedures to isolate residues including 
nitroimidazoles from the potential interferants in foods (Stubbings et al., 2005). A cation 
exchange clean up procedure was developed for use with acetonitrile extracts from 
chicken and turkey muscle and egg. The clean up procedure was employed within 
screening and confirmatory procedures by the reporting laboratory. The point of this 
paper was more related to sample extraction and clean up rather than instrumentation, but 
it is an important part of developing a method and aids in the project work. One of the 
problems especially with MS detection is the presence of interferences that can cause ion 
suppression and poor limits of detection (Diaz-Cruz et al., 2003). For this reason, 
advanced purification techniques, such as immunoaffmity SPE or molecular imprinted 
polymers (MIPs), are required to meet the challenge of analysing drugs in difficult 
matrices. Purification procedures can also include liquid-liquid extraction. Hexane is 
commonly used for lipid removal in the analysis of animal samples (Shao et al, 2009). 
The final and most important method developed for chicken meat and egg was 
adapted for the analysis offish (Mottier et al., 2006). The work in the paper described a 
method for the determination of four 5-nitroimidazoles and three metabolites using LC-
MS-MS. The primary target matrices for validation were eggs and chicken meat, but the 
method was also adapted for analysis offish. A precise and sensitive quantification was 
obtained for 5 of the 7 compounds, but MNZ and its metabolite were unable to be 
quantified. It was recommended they be quantified by means of a matrix matched 
calibration quantification procedure. It was exciting to find a confirmatory method that 
was able to be adapted to fish. 
Several LC methods were developed for meats only, such as poultry and swine. 
These matrices are probably the most closely related to fish tissue. Two of these methods 
are not confirmatory methods, but the extraction procedures were considered potentially 
useful. The first method was for the determination of MNZ, RNZ and DMZ and its 
metabolite in swine tissue by LC with diode array detector, LC-DAD (Shen et al., 2003). 
The SPE column was used to clean up tissues successfully with a minimum number of 
steps and small amount of solvents. In the second method, which is capable of the 
simultaneous determination of six nitroimidazoles and one metabolite in chicken and pork 
by SPE HPLC-UV, the extraction and cleanup conditions were investigated and 
optimized (Sun et al., 2007). 
The other methods for the determination of nitroimidazoles in meat all used LC-
ESI-MS. One used single MS (Hurtaud-Pessel et al., 2000) while the other four used 
tandem MS (Xia et al., 2007, 2008, 2009 and Sun et al, 2009). All five were confirmatory 
methods as even the single MS method monitored several ions for each nitroimidazole 
providing the specificity required for confirmatory analysis. The LC-MS method was 
used to determine DMZ, RNZ, MNZ and HMMNI in poultry meat (Hurtaud-Pessel et al, 
2000). The first LC-ESI-MS-MS method confirmed DMZ, RNZ, MNZ and a metabolite 
in porcine liver at concentrations appropriate for monitoring illegal use of selected banned 
compounds in livestock production (Xia et al., 2007). In the second study LC-ESI-MS-
MS was used for the simultaneous determination of nitrofurans and nitroimidazoles in 
pork (Xia et al., 2008). The nitroimidazole aspect of this method will be useful and 
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possibly the simultaneous determination may also be useful for future work beyond this 
project as nitrofurans are also veterinary drugs that are currently monitored in the lab. 
One of the more recent methods found was for the simultaneous determination of 
four 5-nitroimidazoles (MNZ, RNZ, DMZ and IPZ) and their corresponding metabolites 
(MNZ-OH, IPZ-OH and HMMNI) in swine kidney (Xia et al, 2009) by LC-MS-MS after 
SPE. Another recent method which was considered to be for meat tissue from animal 
origin was for the determination of nitroimidazoles in natural casings by LC-MS-MS with 
SPE (Sun et al, 2009). Natural casing is obtained by extensive processing of fresh 
intestine from healthy livestock and is stuffed with different types of sausage for human 
consumption. This was the only method for the determination of nitroimidazoles in this 
type of tissue. Considering its selectivity, sensitivity and availability to my work LC-ESI-
MS-MS was identified as the method of choice for the thesis project. 
After a thorough search for methods specifically for fish tissue, only two were 
found. In the first paper a HPLC method based on SPE with UV detection was developed 
and validated for the determination of MNZ and MNZ-OH in muscle and skin tissue of 
rainbow trout (Sorenson and Hanson, 2000). It was noted that no validated method had 
previously been reported for the determination of MNZ and MNZ-OH in fish tissues. 
Unfortunately this is not a confirmatory method, but it is still useful, particularly for the 
extraction. Trout is a similar matrix to salmon, one of the representative matrices used to 
validate the project method. The second method was also an SPE-HPLC-UV method for 
the determination of MNZ and MNZ-OH (Maher et al , 2008). It was for tilapia which is 
the representative whitefish matrix used for method validation purposes. These two 
methods combined with the method by Mottier et al. (2006), which was adapted for fish 
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tissue and mentioned earlier, were considered to play the largest role in method 
development and validation. 
2.7 Summary 
This literature review on nitroimidazoles allowed a critical assessment of existing 
information on the following topics: toxicity; stability, depletion and distribution studies; 
the metabolism and methods of analysis for nitromidazoles. The literature has shown 
some of the toxic effects of nitroimidazoles and their metabolites as well as the potential 
risk to human health. The extent of the negative impact on humans, in large part, seems 
unknown. For these reasons, they are banned substances for use in food producing 
animals. The importance of the conditions surrounding sampling and analysis for stability 
purposes to provide reliable results have also been shown. Depletion and distribution 
studies in tissue indicate that target matrices and analytes (parent compound or 
metabolites) require consideration. Information on the metabolism of nitroimidazoles has 
indicated the need to monitor both parent compounds and their metabolites. The need for 
the determination of these residues in our food supply is evident as well. There were 
many methods presented for many different matrices for the analysis of nitroimidazole 
residues. 
It was apparent that very little work had been done on the determination of 
nitroimidazoles in aquacultured fish even though they are used to treat infections in fish. 
Up to this point, only three methods have been found for nitroimidazoles in fish. One of 
these methods was a confirmatory LC-MS-MS method, however the authors failed to 
quantitate one of the most abundantly used nitroimidazoles and its metabolite (MNZ and 
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MNZ-OH). The next was a screening HPLC-UV method for MNZ and MNZ-OH only 
and the third was another screening HPLC-UV method for MNZ and a veterinary drug 
from another class. 
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Chapter 3 - Experimental Materials and Methods 
3.1 Chemicals and Materials 
The analytical standards MNZ, RNZ, DMZ, IPZ-OH, HMMNI and MNZ-OH 
were obtained from Sigma Aldrich (St. Louis, MO, USA). Deuterated dimetridazole 
(DMZ-D3) and IPZ were purchased from Witega (Berlin, Germany). All pharmaceuticals 
were of analytical grade (>99%). 
HPLC grade dichloromethane, methanol, acetonitrile and 2-propanol, hexane 
(distilled in glass) and laboratory grade formic acid (90%) were purchased from Fisher 
Scientific (Fairlawn, N.J, USA). Perchloric acid (60%) was from SEASTAR Chemicals 
Inc. (Sidney, B.C., Canada). Glacial acetic acid came from J.T. Baker (Phillipsburg, NJ, 
USA). Water was purified using a Milli Q water system from Millipore (Bedford, MA, 
USA). 
Individual stock standards at 100|ag/mL were prepared by dissolving 10 mg of 
standard in 100 mL of acetonitrile and were stored at 4°C for 1 year, at which time a fresh 
stock standard solution was prepared. A mixed intermediate standard solution (l(ig/mL) 
was prepared by diluting 1 mL of each stock solution into 100 mL of 0.1% acetic acid. A 
working standard (lOOng/mL) was prepared by diluting 5 mL of intermediate standard 
into 100 mL of 0.1% acetic acid. These were stored at 4°C for 12 months, at which time 
fresh mixed intermediate stock and working standard solutions were prepared. Internal 
standard stock, intermediate and working solutions were prepared at the same 
concentrations using the same dilutions and stored under the same conditions. 
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Waters Sep-Pak C-18 SPE cartridges were purchased from Waters (Milford, MA, 
USA). The 0.2 um nylon membrane syringe filters were purchased from Pall Corporation 
(Ann Arbour MI, USA). 
Sample material including tilapia, salmon and shrimp muscle tissues were 
provided by the CFIA for method development and validation. Live rainbow trout 
(Oncorhynchus mykiss) for the depletion study were provided by the Nova Scotia 
Provincial Fish Hatchery (Caledonia, NS). 
3.2 Sample Preparation 
Prior to sample preparation the material was stored at -80°C. Precautions were 
taken to prevent contamination between samples. Before processing each sample, the 
cutting board, knives, spatulas and the immediate work area were carefully scrubbed to 
reduce the risk of cross-contamination. Fish were partially thawed to facilitate 
preparation, then placed on a cutting board for removal of sample material. For larger 
finfish, three cross sectional slices were removed from each side of the fish, one from just 
back of the pectoral fin, one just back of the vent and one midway between the other two. 
For smaller fish, one fillet from each side of the fish was removed for homogenate 
preparation. Skin, viscera and bones were removed and the tissue was homogenized using 
a domestic food processor. For crustaceans, the meat was removed from the shell and 
homogenized. The homogenate was stored in a sealed container below -20°C until 
analysis. 
3.3 Extraction and Clean Up 
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A 4g test portion of homogenized tissue was weighed into a 50 mL polypropylene 
(pp) centrifuge tube. Test portions of blank tissue were fortified with a 200uL aliquot of 
mixed working standard for recovery determinations. An aliquot (lOOuL) of working 
internal standard was added to each test portion prior to addition of 16mL of 0.08% 
perchloric acid in acetonitrile solution. The tissue and acidic acetonitrile were then 
homogenized using a Polytron tissue homogenizer (PT10-35, Kinematica AG, 
Switzerland) until homogenous and the volume was adjusted to 25 mL with 
dichloromethane. Tubes were placed on a rotator (Glass Col, Terre Haute, USA) for 10 
minutes, and then centrifuged (Allegra XR-15 with SX4750 rotor, Beckman Coulter) at 
53 8g for 10 minutes. A 10 mL aliquot of supernatant was removed to a 14 mL pp Falcon 
tube. For matrix matched standards, three additional samples of blank tissue were 
extracted and five 10 mL aliquots were transported to individual 14 mL pp falcon tubes. 
Tube contents were evaporated to 2 mL under a stream of nitrogen at < 45°C. 
A Waters Sep-Pak SPE cartridge was conditioned with 2 mL of acetonitrile. A 2 
ml portion of concentrated extract was passed through the cartridge and the effluent was 
collected in a 16 x 100 mm disposable glass tube. The extract tube was rinsed with three 2 
mL portions of acetonitrile, passing each rinse through the column and collecting the 
effluent. The SPE column was rinsed with 2 mL of acetonitrile and the effluent collected. 
The effluent was evaporated to dryness under a stream of nitrogen at < 45 °C, and 1 ml of 
acetonitrile added to each tube. To remove fat, a 1 ml portion of hexane was added to the 
extract in acetonitrile and vortexed. This mixture was then centrifuged at 269 g for 5 
minutes, the hexane layer removed and the acetonitrile again evaporated to dryness under 
a stream of nitrogen at < 45°C. For samples and spikes, the residue was reconstituted with 
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1000 (j,L of 0.1 % acetic acid solution and vortexed to ensure the residue was fully 
dissolved. Required volumes used for the preparation of the matrix matched standards are 
given in Table 3.1. The specified volume of working standard and internal standard was 
added and diluted with the specified volume of 0.1% acetic acid and vortexed to prepare 
each of the calibration standards. All samples, spikes and standards were filtered through 
a 0.2 um nylon filter into an auto sampler vial. 
Table 3.1 Volumes of working standard (100 ng/mL), internal working standard 
(lOOng/ml) and 0.1% acetic acid required to provide specified concentrations of the 









































3.4 UPLC-MS-MS Instrumentation 
Chromatographic separation of nitroimidazoles was performed on a Waters 
Aquity Ultra Performance Liquid Chromatography system using a Waters Aquity HSS T3 
CI 8 1.8um particle size, 2.1mm id x 50mm (Waters, Milford, MA, USA) maintained at 
35°C. The mobile phase consisted of 0.1% acetic acid in water (mobile phase A) and 
0.1% acetic acid in acetonitrile (mobile phase B) pumped at a flow rate of 0.4 ml/min. 
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The initial conditions (0-0.5 min) were 95% A. Then the conditions changed to 70% A 
(0.5-5 min) and then to 5% A (5-10 min). The volume of sample injected was 20 uL. 
The UPLC system was coupled to a Micromass Quattro Premier XE triple 
quadropole mass spectrometer (Waters Scientific, Milford, MA, USA) equipped with a 
source capable of operation in electrospray ionization (ESI) and atmospheric pressure 
ionisation (APCI) modes and controlled by MassLynx software (version 4.1). MS tune 
parameters for maximum intensity of precursor ions were as follows: capillary voltage, 2 
kV; extractor voltage, 5V; source temperature, 130°C; desolvation temperature, 450°C; 
cone gas flow, 550L/hr. After initial comparison of performance in both ESI and APCI 
modes, the MS instrument was operated in the ESI positive mode for all compounds in 
subsequent experiments and the data were acquired in multiple reaction monitoring 
(MRM) mode. MRM transitions were optimized during tuning and are summarized in 
table 3.2, with optimized cone voltages and collision energies used in the experiments. 
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3.5 Identification and Quantification 
For each compound being analyzed, the parent ion and the two most intense 
daughter ions were monitored. The first mass transition was used for quantification and 
the second, in combination with the first, for confirmation. This information, as well as 
retention time, was used to ensure correct peak identification. Confirmation of a 
compound was based on the following: the signal to noise ratio for each product ion was 
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at least 3:1; the retention time of the product ions in the sample matched the product ions 
in the standards within 5 % and the ion ratios of the analytes in the samples were ± 20% 
the average ion ratios for the standards (EU, 2002). 
A calibration curve was prepared by plotting concentration of matrix-matched 
standard (ng/mL) versus instrument response. Sample concentrations were calculated 
from the matrix-matched calibration curve correcting for dilutions, mass of extracted 
sample tissue and for recovery from fortified samples. To calculate internal standard 
recovery for each sample, the mean response (area) was calculated for the known 
concentration of internal standard in each calibration standard. From this information a 
calibration factor (area/concentration) was determined and used to multiply by the 
concentration of each standard to give predicted responses (area) for the standards. This 
was used to prepare an internal standard calibration curve by plotting the standard 
concentration (ng/ml) versus response (area). The internal standard concentration in each 
sample was calculated from this curve. Percent recovery was calculated by dividing the 
calculated concentration by the true concentration and multiplying by 100. In this 
instance, the internal standard was used as quality control check for each sample. The 
internal standard was also used to control variability during extraction, sample injection 
and ionization by preparing a standard curve plotting standard concentration (ng/ml) 
against the ratio of sample response to internal standard response. The following 
calculation was used to calculate sample concentration: 
[C]X2.5] 
ng/g= — /%Rec 
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Where C = Concentration in ng/mL as determined from the standard curve 
Wt = Weight of sample used in grams 
% Rec = Percent Recovery 
2.5 = Dilution Factor (25 mL/10 mL) 
3.6 Method Development 
Method development began with a search for suppliers to obtain pure standards 
for the analytes of interest which were determined to be MNZ, RNZ, DMZ, HMMNI, 
IPZ, IPZ-OH, MNZ-OH and DMZ- D3 as the internal standard. After UPLC-MS-MS 
conditions and parameters were determined, the approach for method development 
described in Murphy (2009) was used for determining linearity, matrix effects, 
ruggedness and stability. 
3.6.1 Mass Spectrometry (MS) 
Each analyte was individually infused directly into the MS as a standard solution 
at a concentration of 50 ng/ml for tuning of MRM transitions. Tuning was based on 
available literature information (Mottier et al, 2006) for initial selection of target ions and 
transitions to determine mass transitions for quantification and analyte confirmation. The 
MS probe was capable of both ESI and APCI modes, so all compounds were tested using 
both ESI and APCI in positive and negative modes. APCI was achieved by installing the 
corona pin. Parameters such as cone voltage and collision energy were optimized during 
infusion for each analyte to obtain the maximum sensitivity with the highest amount of 
product ions available, and the two MRM transitions providing best response were 
determined for each molecule. Fragmentation pathways for each molecule and structures 
for each fragment were also proposed. 
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ESI positive mode was chosen for analysis because it gave the best results and it 
was also convenient since other methods for veterinary drugs were routinely performed in 
ESI mode on the same instrument. The appropriate dwell time was set to provide enough 
data points across the peak to give reproducible peak areas for quantification purposes 
and to maintain signal intensity (Hernando et al., 2007). To obtain a sufficient number of 
scans for each compound, dwell time was set for 0.05 seconds for each transition and 
interscan delay was 0.02s. Two separate time windows, one containing 5 compounds and 
the other containing 2 were created to also increase scan counts and improve analysis 
efficiency. All of these parameters were contained in a Tune file in MassLynx. 
3.6.2 Liquid Chromatography (LC) 
Liquid chromatography conditions were established and optimized based on 
information from literature and experimental evaluation. In the literature, 
chromatographic separation of nitroimidazoles was performed in gradient mode using 
water acidified with 0.1 % acetic acid (mobile phase A) and acetonitrile acidified with 0.1 
% acetic acid (mobile phase B) at a flow rate of 0.25 uL/min (Cronly et al., 2009). These 
mobile phases were used for other veterinary drug procedures performed in the lab (CFIA 
Dartmouth Laboratory, SOM-DAR-CHE-037-03, 2007 and SOM-DAR-CHE-038-05, 
2009). A flow rate of 0.4 ml/min was used and two main gradiant elution programs were 
considered from Xia et al (2009) and van de Reit at al (2005). Different variations of 
these gradient profiles were attempted until the best separation was obtained. Initially, 
separation was performed using an Aquity BEH CI8 column (50mm x 2.1mm id 1.7um 
particle size) as described by Tamtam et al. (2009). A Waters Aquity HSS T3 CI8 1.8um 
particle size, 2.1mm id x 50mm was also evaluated and equivalent performance was 
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obtained on both columns. A column temperature of 35°C was used as it was the standard 
temperature for several other veterinary drug methods. Use of a temperature slightly 
above laboratory room temperature eliminates minor variations in chromatography which 
may be caused by fluctuations in the laboratory room temperature during the course of an 
analytical run. Some controllers will not control at room temperature and need to be set 5-
10 °C above or below room temperature. 
3.6.3 Linear Range and Sensitivity of Calibration Curve 
Instrumental linear range for the analytes was determined by the injection of 
standard solutions in order to determine at what concentration the instrument response no 
longer conforms to a linear equation (y= mx +b). The expected concentration range from 
routine samples was not known, however a predicted range was used. Six calibration 
solutions ranging from 10-100 ng/mL made up in 0.1% acetic acid were injected. The 
concentrations of the solutions were evenly spaced to determine the precise level at which 
the calibration curve is no longer linear. The standard concentration (ng/ml) was plotted 
against instrument response to determine the linear portion and sensitivity of the curve. 
The instrument linear range was used to determine the analyte concentration range for 
which the method was fit for purpose. Sensitivity was determined from the slopes of the 
calibration curves. Sensitivity describes the change in instrument response for a given 
concentration change (CAC, 2009b; Anon, 1998). 
3.6.4 Preliminary Extraction and SPE 
In the literature, tilapia fish tissue samples were extracted with a mixture of 0.2% 
orthophosphoric acid-methanol (6:4) followed by a clean-up procedure using a reversed 
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phase CI8 Waters Sep Pak extraction cartridge (Maher et al, 2008). Ethyl acetate was 
used to extract fish tissue after the addition of 0.5 M K2HP04 by Mottier et al (2006). A 
mixture of acetonitrile with hexane (2:1) was used for extraction of trout followed by 
clean up using a silica SPE cartridge (Sorenson and Hanson, 2000). Acetonitrile was also 
used for extraction of nitroimidazoles from other types of samples such as bovine plasma 
(Cronly et al., 2009). Two other veterinary drug residue methods for fish tissue currently 
used by CFIA (SOM-DAR-CHE-050-01 and SOM-DAR-CHE-039-07, 2009) used 
acetonitrile and 0.08% perchloric acid in acetonitrile with Oasis HLB and Waters CI8 
Sep Pak cartridges, respectively. 
Using this information, fortified salmon was extracted using either acidic 
acetonitrile or 100% acetonitrile only followed by Waters Sep-Pak SPE. To determine if 
the Waters Sep Pak cartridges caused loss of analytes, extracts of blank salmon tissue 
were fortified with analytical standards both before and after SPE. Hexane was used in 
previous work with nitroimidazoles (Mottier et al, 2006 and Xia et al, 2007) to remove 
impurities, as well as in other veterinary drug residue methods for fish (Pearce et al, 
2009). Therefore, fortified salmon samples were extracted with and without hexane wash 
for comparison. Several veterinary drug methods for fish tissue included a filtration step 
using 0.2(im nylon filters prior to LC analysis and these were used for this method to 
remove any remaining impurities remaining after extraction, SPE clean-up and hexane 
partitioning. 
3.6.5 Matrix Effects and Method Selectivity 
Three commodities were chosen to determine the effect of matrix on instrument 
response. Fish muscle from tilapia was representative of a low fat fish matrix, salmon a 
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high fat fish matrix and shrimp was the representative crustacean. The matrix can change 
the chromatographic profile or create an enhanced or suppressed response from the 
detector (Gosetti et al., 2010). To determine the matrix effect, calibration curves were 
prepared using both neat and matrix matched standards and compared. Three matrix 
fortified calibration curves were prepared using extracted blank tilapia, salmon and 
shrimp muscle. The extracts were fortified with appropriate aliquots of standards prior to 
reconstitution to give concentrations of 0, 2, 4, 10 and 50 ng/ml. A set of neat standards 
were prepared at the same concentrations. 
Calibration curves for the neat and fortified standards were prepared by plotting 
the average response of the standard solution against the standard concentration. 
Significant differences (>10%) in the slope of the matrix fortified curves compared to that 
of the neat curve or changes in the elution profile would indicate that the matrix did affect 
the instrument response. If there were significant differences between the curves, matrix 
matched standards and/or an internal standard are used. 
In addition to examination of chromatograms to ensure that there were no co-
eluting matrix components which could interfere with the target analytes, other drugs that 
potentially could be present in samples were tested to ensure that their presence did not 
interfere with the analysis. Compounds tested included malachite green (MG), 
leucomalachite green (LMG), crystal violet (CV) and leucocrystal violet (LCV) from the 
triphenyl methane dyes class of drugs; naladixic acid (NAL), oxolinic acid (OXO) and 
flumiquine (FLUM) from the quinolones and the fluoroquinolones including 
ciprofloxacin (CIPRO), danofloxacin (DANO), enrofloxacin (ENRO) and sarafloxacin 
(SARA). 
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3.6.6 Preliminary Determination of Method LOD, Recovery and Precision 
A preliminary estimate of LOD was calculated for each analyte in all three 
matrices based on signal-to-noise and the concentration of the standards analyzed. The 
LOD was estimated by dividing the known concentration of a standard by the signal-to-
noise determined for the analyte peak in the standard and multiplying this by 3, which is 
the minimum signal-to- noise ratio required (Guidance for Industry, 2010). LOD was also 
determined by evaluating the noise level of a blank sample and calculating the 
concentration equivalent to 3 times the noise at the expected retention time for the analyte 
(Eurachem, 1998). 
Preliminary recoveries were also calculated by spiking each commodity in 
duplicate at three concentrations, 1, 2 and 3 ng/g. Preliminary method repeatability was 
done at one concentration, 5 ng/g in tilapia and instrument repeatability was assessed by 
running five injections of each spike level and the fortified material. 
3.6.7 Ruggedness (Robustness) 
Ruggedness (also termed robustness) is a resistance to changes in the results 
produced by an analytical method when minor deviations are made from the experimental 
conditions described in the method (Eurachem, 1998). The ruggedness of the 
nitroimidazole method was tested by introducing small changes to the procedure and 
examining the effect on the results. It was not necessary to perform ruggedness testing on 
all three matrices as matrix effects were investigated previously in method development. 
Tilapia was chosen for ruggedness testing since it was considered representative of the 
most common matrices for the anticipated workload. 
46 
Seven variables were tested and are listed in Table 3.3. Youden's Factorial 
approach, where seven variables can be combined in a specific manner to determine the 
effects of all seven variables using eight combinations in a single experiment, was used 
(Youden and Steiner, 1975). The experiment was carried out in duplicate over two 
separate days to eliminate the chance of a single sample affecting the outcome. Blank 
tilapia tissue was fortified with a mixed standard to give a concentration of 5 ng/g of each 
analyte. 









Add 16 ml of acidic acetonitrile 
Dry extract to 2 ml 
Evaporate eluent to dryness at 45°C 
Use 0.1% acetic acid as the make 
solvent 
Wash with 1 ml of hexane 
Use 0.2 urn nylon filters 









Add 10 ml of acidic acetonitrile 
Dry extract completely 
Evaporate eluent to dryness at 65°C 
Use water as the make up solvent 
Wash with 0.5 ml hexane 
Use 0.2 um Teflon filters 
Do not condition SPE 
The variables to be tested set up into various factor combinations were listed in 
table 3.4, each one giving a measurement of s to z. 
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To determine the effect of each individual factor, the following was calculated. 
Effect of A and a: [(s + t + u + v)/4] - [(w + x + y + z)/4] = J 
This simplifies to: (4A/4) - (4a/4) = J 
Effect of B and b: [(s + t + w + x)/4] - [(u + v + y + z)/4] = K 
Effect of C and c: [(s + u + w + y)/4] - [(t + v + x + z)/4] = L 
Effect of D and d: [(s + t + y + z)/4] - [(u + v + w + x)/4] = M 
Effect of E and e: [(s + u + x + z)/4] - [(t + v + w + y)/4] = N 
Effect of F and f: [(s + v + w + z)/4] - [(t + u + x + y)/4] = O 
Effect of G and g: [(s + v + x + y)/4] - [(t + u + w + z)/4] = P 
The values calculated for the differences between factors J-P were examined. 
Factors which created statistically significant changes were determined by performing a 
two-sample t-test. Equal variance for each factor was assumed. If the p-value was <0.05 
the factor was considered significant, if the p-value was >0.15, the factor was not 
significant and if 0.05<p<0.15, the factor might have been significant. If factors were 
significant, the procedure was changed to reflect this. 
3.6.8 Internal Standard 
Initially an internal standard (IS) was added to the procedure during method 
development and was used as a quality control check for the method. The IS was added to 
each standard and sample and the percent recovery was calculated for each sample. The 
internal standard chosen was DMZ-D3. It was not feasible to have IS for all seven 
compounds as that was too expensive. It was later decided, based on observations made 
during method validation, that internal standard responses would also be used in the 
calibration curve to determine sample concentrations. 
3.6.9 Stability 
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The stability of nitroimidazoles in standard solution, in matrix and in sample 
extract was investigated. The investigation was initiated during method development and 
continued into method validation. 
3.6.9.1 Light Sensitivity 
Nitroimidazoles were reported to be very light sensitive in one paper (Hurtaud et 
al, 2000) and were stored in the dark and /or in amber glassware in several other methods 
(Ho et al, 2005 and Xia et al, 2008). However, light sensitivity was not reported for 
storage conditions on the certificate of analysis for the analytical standards. To determine 
if nitroimidazole standards were light sensitive in solution, a mixed working standard was 
prepared and divided into two portions. One portion was stored under ultraviolet light for 
24 hours and the other portion was stored in the dark. After the 24 hour period, neat 
standards were prepared at 0, 2, 4, 10 and 50 ng/ml concentrations and calibration curves 
for each prepared and compared. If a slope difference of <10% was determined for an 
analyte there was considered to be no significant difference between the two sets of 
standards. Ten 20 ng/ml standards from both the light protected and the UV exposed 
working standard solutions were also prepared. These were analyzed and the average area 
counts calculated for each. The % RSD was calculated between the two averages. 
3.6.9.2 Standard Solution Stability 
Stability of analyte in standard solution was determined by a comparison of a 
working standard that was prepared fresh with one that had been stored at 4°C. 
Comparisons were made weekly for the first month, monthly for 6 months and then 
bimonthly until a year. The % RSD was calculated between old and freshly prepared 
standard to determine if the stability of the old standard had been compromised. 
3.6.9.3 Stability During Processing/Extract Stability 
During method development, recoveries were monitored to determine if any 
significant loss of analyte occurred at any step(s) in the method and if any such losses 
observed could be attributed to stability issues. To determine extract stability, 
representative vials from recovery studies described in section 3.7.2 at each concentration 
level studied were analyzed daily for 5 days. The mean concentration, SD and % RSD 
was calculated for each compound at each concentration. The mean concentration at each 
time point was plotted with error bars representing the SD. The extracts were considered 
stable if the error bars remained within the range of one another and/or %RSDs were < 
the %RSD seen during repeatability studies. 
CUSUM charts were used to see any changes in the extracts over the 5 days. 
CUSUM values were calculated by using the first actual raw data value as the first 
CUSUM point. The second point for CUSUM takes the previous point (raw data value), 
adds the new data value, and subtracts the fixed average of raw data results. Control 
limits were set using two times the standard deviation of the results on day 1. If several 
points were found below the lower control limit, this indicated degradation of the analyte. 
Paired t-tests and ANOVA (analysis of variance) were also applied to the extract 
results. The t-test was used to determine if there was a significant difference between day 
1 results and each of the following days. If the 2 tailed p-value was <0.05, the results 
were considered significantly different. A p-value of 0.05 or greater indicated no 
difference between two groups of results. To compare the results from each day with one 
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another, the ANOV A test was used to determine if the variance between days was 
statistically significant. If the F statistic was determined to be smaller than the critical F 
value, the differences between values over time were not significant. 
3.6.9.4 Tissue Stability 
Analyte matrix stability was determined by analyzing samples with known 
concentrations biweekly over a 2 month period. Fortified samples of tilapia muscle were 
prepared at two concentrations, lng/g and 10 ng/g. Samples of both concentrations were 
pre weighed into 50 ml polypropylene tubes. Five replicates were weighed out for each 
time point over the course of the stability study for two temperature conditions, -20°C and 
-80°C. To represent the typical storage conditions and the effect of freeze/thaw cycles on 
prepared samples, sealed containers of sample at both concentrations were stored at -20°C 
and removed from the freezer, thawed and refrozen at each time point. 
Results from this study were graphed to determine if concentrations changed over 
time. The average of the results from 5 replicates over a 2 month period at each time point 
was plotted on a graph. The standard deviation of the replicates was used as error bars on 
each point on the graph. This was done for each analyte at 2 different concentrations for 
all conditions. If the error bars were within the range of another set of error bars on the 
same graph, then the analyte in tissue was considered to be stable. 
CUSUM charts were also used to display running totals of the differences in 
results from the average at time 0. Control limits were set using two times the standard 
deviation of the results at time 0. 
51 
The %RSD of replicate results from time 0 to 8 weeks was calculated and 
reviewed to determine if they were typical of those seen in repeatability studies. T-tests 
were used to identify any significant differences between time 0 results and the other time 
points. To see any significant differences within all time points ANOVA was used. 
3.7 Method Validation 
For the validation study, experimental parameters determined included 
LOD/LOQ, recovery, repeatability, intermediate precision and measurement uncertainty 
(MU). These parameters were determined based on a written standard operating 
procedure which outlined the validation of analytical methods by the Chemistry section of 
the CFIA Dartmouth Laboratory to meet required performance criteria of a method (SOP-
DAR-CHE-001-00, CFIA), based on recommendations from the International Union of 
Pure and Applied Chemistry (Thompson et al, 2002). In addition, the parameters decision 
limit (CCa) and detection capability (CCp) required in European Commission regulations 
for methods used in veterinary drug residue analysis were also determined (EC, 2002). 
3.7.1 LOD and LOQ 
LOD is the lowest concentration of analyte in a sample that can be detected, but 
not reliably quantified under the stated conditions of the test. LOD was determined for 
each analyte in all commodities including tilapia, salmon and shrimp muscle tissue. This 
was done by evaluating the noise level of 5 blank samples per run on four separate days 
(n=20). The LOD for each blank was determined by calculating the concentration 
equivalent to 3 times instrument noise at the expected retention time for the analyte. The 
LOQ was a mathematical determination based on the LOD and represents the smallest 
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amount of analyte in a test sample that can be quantitatively determined with suitable 
precision and accuracy under previously established method conditions. The LOQ was 
calculated by multiplying the LOD by 3 (Codex, 2009b). 
3.7.2 Accuracy (Trueness and Bias) 
Recovery studies were done to determine the accuracy of the method for the 
analytes being validated in the specified matrices. The fraction recovered of the total 
analyte added is usually expressed as a percentage; thus the per cent recovery represents 
the trueness of the method, while the difference between the recovery and the actual 
quantity of analyte added to the matrix represent the method bias, which may be positive 
or negative (Eurachem, 1998). A recovery greater than 100% indicates a positive bias, 
while a recovery less than 100% indicates a negative bias. 
The recovery of each analyte in tilapia, salmon and shrimp muscle was 
determined by analyzing each matrix fortified with a specified amount of the analyte. 
This was carried out on three fortification levels. Five fortified samples were analyzed at 
each level on one day and this was repeated on two other days for a total of three runs. 
The mean, SD and % RSD for each of the three levels was calculated. Nitroimidazoles 
were banned in all food animals and therefore there were no regulated levels or 
established maximum residue limits (MRLs) for these compounds. The fortification 
levels chosen for each analyte were 3 X LOD (approximately the LOQ), 10 X LOD and 
the upper limit of the linear range of the calibration curve (CAC, 2009b). 
3.7.3 Precision 
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Both instrument and method repeatability were determined. Instrument 
repeatability was determined by repeat injections of prepared standard used for the 
calibration curve as well as a fortified sample at each of the 3 fortification levels from the 
recovery study. Each sample was injected 5 times in random order to prevent any bias. 
The mean, SD and % RSD were calculated. 
Method repeatability was determined by analyzing five replicate extractions of 
fortified material at the same levels that were used in the recovery study. This process 
was done three times on separate days. The mean, SD and % RSD were calculated. 
Intermediate precision expresses the closeness of agreement between a series of 
measurements obtained from multiple sampling of the same homogeneous samples under 
prescribed conditions, which typically include experiments conducted by different 
analysts, over extended timescales, within a single laboratory (Eurachem, 1998). 
Intermediate precision was performed by a second analyst with reagents prepared by the 
second analyst. This parameter was used to determine if there were analyst-related biases 
in the method. The same material prepared for method repeatability was used for 
intermediate precision. The second analyst prepared fresh reagent and samples were 
extracted and analyzed in replicate (5) over 3 separate days. The average, SD and %RSD 
were calculated both separately and with method repeatability results. HorRat values were 
calculated from these results (Horwitz and Alpert, 2006). The HorRat is the ratio of the 
reproducibility relative standard deviation to that calculated from the Horwitz equation 
(CAC, 2009b). 
3.7.4 CCa and CCp 
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The decision limit (CCa) is the limit at and above which it can be concluded with 
an error of probability of a that a sample contains the analyte (EC, 2002). CCa was 
determined by analyzing 5 blank samples on four analysis days. The concentration 
equivalent to 3 X the instrument noise was calculated at the expected retention time for 
each analyte using the regression equation obtained from the calibration curve. The 
average of the 20 determinations for each matrix was the CCa for that matrix. 
Detection capability (CCJ3) is defined as the smallest content of the substance that 
may be detected, identified and/or quantified in a sample with an error of probability of P 
(EC, 2002). A total often blank samples, fortified at the determined CCa for each matrix 
were prepared on two separate days. Samples were analysed and the analytes identified. 
The concentration of the samples was determined from the standard curve and the 
average, SD and %RSD were calculated. The detection capability was determined as the 
decision limit plus 1.64 times the standard deviation of the values obtained. 
3.7.5 Measurement Uncertainty (MU) 
MU is defined as a parameter associated with a result of a measurement that 
characterises the dispersion of the values that could reasonably be attributed to the 
measureand (JCGM, 2008). The uncertainty of this method was grouped into two 
categories; accuracy and precision. The MU was estimated by taking into account the 
recovery results which represented accuracy and the data sets that were assessed against 
precision were from intermediate precision results (Ellison et al, 2000). The calculation 
used for determining the relative uncertainty of the method was the square root of the sum 
of the squares of the respective relative uncertainties for accuracy and precision. 
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UofM = ̂ {R U {accuracy) + R U {precision) 
3.8 Depletion Study 
A depletion study under controlled conditions was conducted to determine 
depletion time in muscle tissue from initial treatment of the drug until residues were no 
longer detectable. The most commonly used nitroimidazole compound, metronidazole, 
was used to conduct the depletion study in rainbow trout. Only two previous papers have 
been published on the metabolism of MNZ in fish, one in trout (Sorenson and Hanson, 
2000) and the other in tilapia (Maher et al., 2008). 
The Bedford Institute of Oceanography (BIO) fish lab was the location chosen to 
complete the depletion study. Dr. Jocelyne Hellou from the Department of Fisheries and 
Oceans (DFO) provided help with conducting the exposure, plus advice and access to the 
fish lab facilities to prepare fish samples representative of real case ones. Rainbow trout 
and feed were provided by the Nova Scotia Provincial Government fish hatchery in 
Caledonia, NS. Feed originated from Corey Feed Mills Ltd in Fredericton, NB. 
To use a banned substance such as metronidazole, it was required that an 
application for an Experimental Studies Certificate (ESC) for a veterinary drug be 
completed and sent to Health Canada for approval. The application was reviewed by the 
Clinical Evaluation Division (CED) and the Human Safety Division (HSD). An Animal 
Use Protocol form was also completed and submitted to the Maritimes/Gulf/CFIA 
Regional Animal Care Committee. Prior to submission of the form it was required that I 
complete an online Experimental Fish Course that was offered by the Canadian 
Aquaculture Institute at the University of Prince Edward Island. 
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Since more than one organization was involved in the depletion study it was 
necessary that an agreement in the form of a Letter of Understanding (LOU) was written 
and signed to outline the responsibilities of the two parties, CFIA and DFO. Security 
clearance for CFIA employees for entrance into BIO was also required. 
3.8.1 Preparation of Medicated Diet 
Medicated feed was prepared at the BIO facility, using the same feed pellets the 
fish were fed prior to the medication period and MNZ that was purchased from Sigma, at 
a concentration of 3 g/kg of feed. The MNZ was dissolved in acetone and the food pellets 
coated with the solution. The acetone was evaporated by air drying for 24 hours at room 
temperature leaving the MNZ residue on the pellets. The medicated pellets were stored at 
-20C until use. Prior to feeding, small quantities were thawed and refrigerated until fed. 
A sample of the pellets was extracted and analyzed by LC-MS-MS to determine 
the concentration achieved. The pellets were crushed by mortar and pestle, then extracted 
as in section 3.3, except only 1 g of material was weighed out and 3 ml of water added. 
Dilutions of 105 and 106 times were done to avoid contamination and to keep 
concentrations within the standard curve. Non medicated feed was spiked at the expected 
concentration (3 g/kg) of the medicated feed and treated the same to account for any losses 
during sample preparation and analysis. Samples were analyzed as in section 3.4 and 
results calculated as in section 3.5 taking into consideration the change in sample weight 
and the dilutions. 
3.8.2 Preparation of Incurred Fish 
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Seventy three rainbow trout (approximately 200g in size) were transported from 
the Caledonia, NS fish hatchery to BIO fish labs by truck using aerated tanks. Once 
relocated to BIO, the fish were housed in two separate tanks capable of holding forty fish 
each and maintained under the same conditions (water temperature, dissolved oxygen, 
etc.). Water quality parameters were measured periodically. The Fish Laboratory 
Manager recorded the supply water temperature for the tanks daily at approximately 9:00 
am. Faeces and any residue at the bottom of the tank was vacuumed out and placed in 
buckets to settle, then transferred in jars, autoclaved and disposed of by CFIA along with 
other lab waste chemicals. 
Fish were fed commercial food pellets from Corey Feed, which was used at the 
hatchery, prior to exposure to the prepared medicated feed and during the withdrawal 
periods. Feeding was done once daily as required by the Animal Care Committee. Fish 
were acclimated for 2 weeks at BIO prior to the study to ascertain the amount of feed that 
would be consumed by the fish under new holding conditions. Fish were fed the 
medicated diet during two five day medicated periods and the drug free diet during 
acclimation and withdrawal periods at a level of 1% body weight. Feeding was the same 
as in a typical aquaculture farm. Fish were fed as a group in the tanks and access of 
individual fish to feed was not controlled. 
3.8.3 Sampling of Fish 
Immediately prior to the first feeding of the medicated diet, seven fish were 
sampled as controls. The fish were sacrificed with a blow on the head so as to not add 
potential interferences while undergoing chemical analysis. The first sampling was 
followed by 2 samplings during the 5 day medication period (after 3 and 5 days of 
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medication) and three samplings during the 5 day withdrawal period (after days 6, 8 and 
10 from the medication, i.e. days 1, 3 and 5 of withdrawal). The sample size at each time 
point was 7. A second 5 day medication period was also done with a 16 day withdrawal 
period. Samples were taken on day 6, 12, 15, 18 and 22 after medication (i.e. days 1, 6, 9, 
12 and 16 of withdrawal). The sample size at each time point was 5. All fish sampled 
were weighed and measured prior to being filleted and frozen at -80°C. Fish were 
sacrificed at BIO, placed on ice and transported immediately to the adjacent CFIA facility 
(1-2 minutes between facilities). 
3.8.4 Chemical Analysis 
Samples were prepared as per section 3.2. Homogenized samples were extracted 
using acidic acetonitrile followed by C-18 SPE column clean up explained in section 3.3. 
Analysis was performed in duplicate by UPLC-MS-MS following the parameters outlined 
in section 3.4. Quality assurance guidelines were maintained using spike recoveries and 
an internal standard. 
Results were calculated from a calibration curve prepared as in section 3.5. The 
mean, SD and % RSD were calculated for the results at each time point. Results were 
plotted to show change in concentration with time. 
3.8.5 Disposal of Waste from Tanks Following Depletion Study 
Since nitroimidazoles are banned substances, it was necessary to avoid external 
contamination to the water system. Faeces and any residue at the bottom of the tank was 
vacuumed out and placed in buckets to settle, then transferred in jars, autoclaved and 
disposed of by CFIA along with other lab waste chemicals. 
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3.8.6 Tissue Disposal 
Incurred tissue not required for analysis in the depletion study were maintained in 
frozen storage and for use as analyst training and quality control materials once routine 
analysis of CFIA survey samples commences. Any stored materials which become unfit 
will be disposed as laboratory waste. 
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Chapter 4 - Results and Discussion 
4.1 Method Development 
The development of an analytical method for very low concentrations of a residue 
or contaminant in a food usually involves three major steps. First, the detection 
parameters are determined for standards of the analyte. Second, a chromatographic 
separation is developed using standards of the analyte. Finally, procedures are 
investigated to extract the analyte from the matrix and to remove most co-extractives and 
potential interferences, using procedures such as solid phase extraction. When mass 
spectrometric detection is used in combination with liquid chromatographic separation, 
additional studies must be conducted to determine if matrix effects can enhance or 
suppress the response from the analyte, thus providing information on whether calibration 
curves may use pure standards or whether alternative approaches, such as fortification of 
blank matrix with standards or use of internal standards, is required (Matuszewski et al, 
2003). The investigations conducted during methods development in this research 
followed this general approach and the results of these investigations are presented in the 
following sections. 
During the development of a residue method it is important to perform extraction 
and clean up experiments. Typically methods to determine nitroimidazoles involve 
extraction with an organic solvent, followed by SPE, in order to clean up the extracts 
prior to determination (Mahugo-Santana et al, 2010). Sample extraction is necessary in 
order to isolate and concentrate the target compounds from complex matrices because 
most analytical instruments cannot handle the sample directly. Many nitromidazole 
residue methods use ethyl acetate or acetonitrile to extract the residues from biological 
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samples followed by SPE in order to clean up the extract. Also, to aid in eliminating 
impurities, agents such as hexane can be added. 
To determine an extraction and clean up procedure, experiments were based on 
observations from literature as well as procedures used for other veterinary drug residue 
classes monitored in the CFIA Dartmouth laboratory. The organic solvents and SPE used 
which gave the best recoveries were chosen for the method. 
LC-MS has become the instrument of choice for drug residue analysis including 
nitroimidazole residues (Mahugo-Santana et al., 2010). Single MS is being replaced by 
tandem MS to achieve confirmation of analyte identity. LC-MS-MS was chosen for 
development of the method for its confirmation capabilities. 
UPLC takes advantage of technological strides made in particle-chemistry 
performance (Mahugo-Santana et al, 2010). The use of UPLC in the development of this 
method allowed the use of columns and instrumentation that are operated under higher 
pressures which resulted in increased resolution, sensitivity and speed of analysis. All 
seven nitroimidazole compounds investigated were separated in under 5 minutes. See 
table 4.2 in section 4.1.2 for retention time of the analytes. 
Gradient elution is commonly used in LC using a binary system including an 
aqueous component and a less polar organic solvent with a weak acid buffer to maintain 
appropriate pH (Mahugo-Santana, 2010). A water-acetonitrile gradient with 0.1% acetic 
acid was chosen and shown to give good separation and resolution of the analytes 
included in the method. 
Data results reported in this chapter were rounded according to Miller and Miller, 
(2005) and the raw data contained in the appendices were not rounded. As per Miller and 
62 
Miller, the standard deviation dictated the number of significant figures that were 
reported, with uncertainty being associated with the number indicated by precision. 
Therefore, a standard deviation of 0.1 indicates uncertainty at the first digit following the 
decimal and no additional figures are reported. 
4.1.1 MS 
The parent compounds MNZ, IPZ, RNZ and DMZ along with their metabolites 
MNZ-OH, IPZ-OH and HMMNI were monitored using MS-MS detection. Both APCI 
and ESI interfaces have been applied for LC-MS analysis of nitroimidazoles usually 
under positive ionization conditions (Sams et al, 1998 and Hurtaud-Pessel et al., 2000). 
ESI in positive mode gave the most favourable analyte responses during development. 
According to Commission Decision 2002/657/EC MSMS (EC, 2002) and Codex 
Alimentarius Commission Guideline CAC/GL 71-2009 (CAC, 2009a) methods are 
required to have a precursor (parent) ion plus two characteristic transition ions for 
confirmation of each target analyte. Mass spectra were recorded for each analyte at 
various cone voltages to give the best response followed by the application of different 
collision energies to select two daughter ions for each parent. Table 4.1 summarizes 
parent ions and their daughter fragments necessary for quantification and confirmation of 
the analytes. 
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Fragmentation pathways for nitroimidazole molecules were discussed in two 
previously published papers (Mottier et al, 2006 and Sun et al, 2009). The proposed 
fragmentation pathway of the mass fragments used for each molecule studied is explained 
in the following and shown in figure 4.1. 
IPZ and IPZ-OH 
IPZ (m/z 170) fragmented with a loss of NO2 (46 Daltons (Da)) to produce m/z 
124 and CH3N02 (61 Da) to give m/z 109. According to Mottier et al., 2006, the CH3 is 
released when the imidazole ring opens, while Sun et al, 2009 propose the CH3 is released 
from outside the ring. The compound IPZ-OH (m/z 186) gave a fragment with m/z 168 
following a loss of H2O, then NO2 was also eliminated giving a radical cation (m/z 122). 
MNZ and MNZ-OH 
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The mass spectra for MNZ (m/z 172) contained fragment ions at m/z 128 and 82. 
The loss of C2H3OH (44 Da) led to m/z of 128, followed by a further loss of N0 2 from 
this fragment producing a radical cation with m/z 82. For the metabolite MNZ-OH (m/z 
188), the main fragments were at m/z 126 and 123. The elimination of H2O and C2H3OH 
(62 Da) gave m/z 126. The losses of NO2 and H2O followed by a cyclization of the 
residual fragment gave m/z 123. 
DMZ, RNZ and HMMNI 
The fragmentation pathway for DMZ (m/z 142) was similar to IPZ. The fragment 
at m/z 96 represented the loss of NO2 while a further loss of CH3 produced a fragment at 
m/z 81. For RNZ (m/z 201), the ion observed at m/z 140 resulted from the loss of 
CH3NO2 (61 Da) and the ion at m/z 55 was due to a loss of C4H6O4N2 (146 Da) which 
results from the opening of the imidazole ring. The precursor molecular ion for HMMNI, 
which had a mass to charge ratio (m/z) of 158, had a fragment ion at m/z 140 from the 
loss of H2O and an ion at m/z 55 from the loss of C2HNO2 and CH3OH when the 
imidazole ring opens, for a total of 103 Da. 
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Figure 4.1 Proposed MS ion formation for IPZ, IPZ-OH, MNZ, MNZ-OH and DMZ (a), 
RNZ and HMMNI (b) and an alternative pathway for DMZ and IPZ (Mottier et al, 2006) 
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4.1.2 LC 
Typical chromatograms of blank tilapia muscle and tilapia muscle spiked at 1 ng/g 
with HMMNI, IPZ, IPZ-OH, MNZ, MNZ-OH, RNZ and DMZ are shown in figure 4.2. 
Similar chromatograms of salmon and shrimp muscle are shown in figures 4.3 and 4.4. 
Chromatographic separation was achieved for all 7 analytes using the chosen gradient. 
Analytes were well separated within 5 minutes with a total run time of 10 minutes 
including re-equilibration. Retention times for compounds are shown in table 4.2. 
67 
(a) 
RNZ1 98 2 61 2 Z 9 
100 2 00 3 00 4 00 5 00 6 00 7 00 8 00 9 00 10 00 
(b) 
100 2 00 3 00 4 00 5 00 6 00 7 00 8 00 9 00 10 00 
3 27 
IPZ OH 
100 2 00 3 00 4 00 5 00 6 00 7 00 8 00 9 00 10 00 
1 82 
A MNZ 
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5 00 6 00 7 00 9 00 10 00 
157 8>139 9 
100 2 00 3 00 4 00 5 00 6 00 7 00 8 00 9 00 10 00 
1 00 2 00 3 00 4 00 5 00 6 00 7 00 8 00 9 00 10 00 
Figure 4.2 Chromatograms of tilapia fish tissue extract: blank tissue (a), tissue 
fortified with 1 ng/g nitroimidazoles (HMMNI, IPZ, IPZ-OH, MNZ, MNZ-OH, RNZ and 
DMZ (b). The blank chromatogram is labelled with expected retention times of analytes. 
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Figure 4.3 Chromatograms of salmon fish tissue extract: blank tissue (a), tissue fortified 
with 1 ng/g nitroimidazoles (HMMNI, IPZ, IPZ-OH, MNZ, MNZ-OH, RNZ and DMZ 
(b). The blank chromatogram is labelled with expected retention times of analytes. 
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Figure 4.4 Chromatograms of shrimp fish tissue extract: blank tissue (a), tissue fortified 
with 1 ng/g nitroimidazoles (HMMNI, IPZ, IPZ-OH, MNZ, MNZ-OH, RNZ and DMZ 
(b). The blank chromatogram is labelled with expected retention times of analytes. 
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Table 4.2 Retention times, Correlation Coefficients (R2) and equations from calibration 




























y = 909.52x-701.03 
y = 2352.1x +227.93 
y = 2585.6x + 4894.3 
y=1656.9x + 5502 
y = 458.98x +217.58 
y=1094x+1509.7 
y=1999.5x- 1370.1 
4.1.3 Linear Range and Sensitivity 
A standard curve was tested at 0, 10, 20, 40, 60, 80 and 100 ng/ml nitroimidazoles 
(NIs). The standard calibration curves were linear for all analytes with correlation 
coefficients (R2) > 0.9941. Correlation coefficients for each analyte are in table 4.2. From 
this information, it was decided calibration curves with standards 0, 2, 4, 10 and 50 ng/ml 
would be used when determining matrix effects and for routine analysis of samples. 
Linear range was determined to be 0-62.5 ng/g, which was used to determine the 
analytical range of 0.3 - 62.5 ng/g. This was further tested during validation studies. 
Sensitivity was determined from the slopes of the calibration curves. Sensitivity 
describes the change in instrument response for a given concentration change (CAC, 
2009b; Anon, 1998). It is represented by the slope of the calibration curve and can be 
determined by using samples containing various concentrations of the analyte. The slopes 
were neither too steep nor too shallow and were considered suitable to produce reliable 
analytical results. As shown in figure 4.5 the slope of the curve has an angle of inclination 
that lies between 30 and 60 degrees. This was true for all nitroimidazole analytes and the 
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calibration equations are in table 4.2. Consistent change was observed in detector 
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Figure 4.5 Calibration curve for HMMNI using neat standards 
4.1.4 Preliminary Extraction and SPE 
In the first experiment, spiked salmon muscle samples were extracted with either 
acidic MeCN (0.08% perchloric acid) or 100 % MeCN followed by SPE cleanup using 
CI8 Waters Sep Pak cartridges. Very low recoveries resulted with the 100% MeCN 
extraction and better recoveries ranging from 41-62%) were obtained with acidic MeCN. 
To determine if the chosen SPE CI 8 Sep Paks caused the loss of analytes, spikes 
were added both before and after the SPE step. Acidic MeCN was used for extraction 
since it had improved recoveries compared to 100% MeCN. Recoveries were similar for 
both spiking before and after SPE, which indicated the SPE was not causing the loss of 
analyte. 
In an attempt to improve recoveries, a hexane wash was added to remove fat and 
other impurities. This provided an improvement with mean recoveries for all analytes 
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with hexane wash ranging from 85 to 106%. Method development continued using acidic 
MeCN, CI8 SPE and a hexane wash. 
The intermediate precision "includes the same measurement procedure, same 
location, and replicate measurements on the same or similar objects over an extended 
period of time, but may include other conditions involving changes", such as "new 
calibrations, calibrators, operators, and measuring systems" (JCGM, 2008). During 
method validation a problem with the hexane wash step was discovered when a second 
analyst was analysing salmon to assess intermediate precision of the method. The hexane 
wash step was originally conducted after the final extract was made up in 0.1% acetic 
acid solution. However, vigorous vortexing of the hexane and 0.1% acetic acid with fatty 
extract such as salmon, caused emulsions to form. While the analytes are not fat soluble, 
the emulsion formation did interfere with recovery and analysis. This had not been a 
problem seen by the first analyst. To avoid future issues with emulsions that may not 
separate, the hexane wash was done while the extract was in acetonitrile, before 0.1% 
acetic acid was added to the final extract. The acetonitrile and hexane layers easily 
separated even after vigorous vortexing. Analyses with fortified salmon, shrimp and 
tilapia were repeated at concentrations of 1, 10 and 50ng/g with the change in the hexane 
wash step. The % RSDs calculated between results with the original and the new hexane 
steps were within the acceptable range for method repeatability (table 4.3). T-tests were 
also performed on the data to determine any significant differences. An example of a t-
test and raw data for the hexane wash results are in Appendix 1. No significant difference 
between results was seen for shrimp muscle. As shown in table 4.3 all two tailed p-values 
were >0.05 for sample size of 15 (n=15). Some p-values for tilapia and salmon were 
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<0.05, however this was due to a smaller sample size (n=5). This method verification was 
accepted based on the shrimp p-values and the acceptable % RSDs for all commodities 
and was written into the procedure. 
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Table 4.3 RSDs and p-values calculated between nitroimidazole results obtained using 
the original and new hexane step for muscle from tilapia, salmon and shrimp. (See 















































































































































































4.1.5 Matrix Effects and Selectivity 
The common perception has been that MS-MS detection is highly selective and 
thus ion suppression or enhancement caused by sample matrix and interferences from 
metabolites is eliminated (Matuszewski, B.K. et al., 2003). However, co-eluting, 
undetected matrix components may affect the intensity of the analytes and effect 
reproducibility and accuracy of the method. Regulatory requirements include the need for 
the assessment of matrix effect during development and validation of LC-MS-MS 
methods. The recommended approach (Matuszewski, B.K. et al., 2003) is to compare the 
MS response for analytes spiked into extracts of blank matrix (matrix matched standards) 
with the response for pure standards to assess matrix effects, then to compare the 
response obtained for standards spiked into blank matrix (matrix fortified standards) prior 
to extraction with the response for standards spiked into extracts of blank matrix to assess 
recovery. 
Matrix effects were revealed by comparison of the slopes of neat and matrix 
matched standard curves. The absolute values of the % differences between the slope of 
the neat standard curve versus matrix matched were > 10% for all analytes, which 
indicated it was necessary to perform analysis using matrix matched standards and/or an 
internal standard (IS). Correlation coefficients for both neat and matrix matched 
calibration curves for each analyte in all three matrices tested; along with calibration 
equations and slope differences are shown in table 4.4 for tilapia muscle, table 4.5 for 
salmon muscle and 4.6 for shrimp muscle. Responses of the standards for the neat 
calibration curves were higher than those of the matrix matched which indicated ion 
suppression from the detector. This can be seen in figure 4.6 for HMMNI in tilapia 
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muscle, figure 4.7 for HMMNI in salmon muscle and figure 4.8 for HMMNI in shrimp 
muscle, in which both curves are compared. 
77 






















y = 2663.2x-867.17 
y = 3427.2x +337.27 
y = 2864.3x+1124.9 
y = 755.14x+164.24 
y=1656.5x + 427.38 












y = 965.11x- 66.015 
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y = 2656x +880.98 
y = 2256.4x + 670.87 
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y = 562.63x +69.507 
y=1235.1x + 327.66 
































y = 3041.5x-1420.4 
y = 2912.7x+130.53 
y = 2481.1x-558.31 
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y =1857.8x + 301.25 
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Figure 4.7 Comparison of neat and salmon matrix curves for HMMNI 
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Figure 4.8 Comparison of neat and shrimp matrix curves for HMMNI 
It was necessary to determine if there were any significant interferences in the 
identification and /or quantification of results (EC, 2002). It can be observed from figures 
4.2, 4.3 and 4.4 that there were no co-eluting peaks in the matrices. The chromatogram in 
figure 4.9 of tilapia muscle spiked with fluoroquinolones, quinolones and triphenyl 
methane dyes showed there were no interferences from these veterinary drugs, which 
could be present in test materials. Trout material incurred with MNZ and MNZ-OH was 
also spiked with these other vet drug classes and compared with the incurred material 
without spike added. Similar results were obtained with or without the other classes of 
drugs present (table 4.7). The % RSD calculated from the mean and SD of both results 
was within acceptable repeatability results. In addition, recoveries did not suggest the 
presence of significant co-eluting peaks (see Section 4.1.6). 
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1 00 2 00 3 00 4 00 9 00 10 00 
1 00 2 00 
IPZ-OH 3 27 
2 00 3 00 
5 00 6 00 
5 00 6 00 
7 00 8 00 9 00 10 00 
9 00 10 00 
2 00 3 00 4 00 5 00 7 00 8 00 
5 00 6 00 7 00 8 00 
1 00 2 00 5 00 6 00 9 00 10 00 
Figure 4.9 Chromatogram of blank tilapia tissue spiked with fluoroquinolones, 
quinolones and triphenyl methane dyes. The chromatogram is labelled with expected 
retention times of NI analytes. 
Table 4.7 Comparison of MNZ and MNZ-OH results for incurred trout samples spiked 
































Each NI investigated for the method was identified with a precursor ion and two 
product ions. All analytes had different precursor and product ions providing selectivity. 
Also, other analytes from different classes of veterinary drugs which may be present in 
material being tested for NIs, have different precursor and product ions. 
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4.1.6 Preliminary LOD, Recovery and Precision 
LOD was first estimated during method development for each analyte in all three 
matrices to be between 0.1 - 0.3 ng/g based on signal-to-noise and the concentration of 
standards analyzed. It was then determined to be approximately 0.1 - 0.3 ng/g by 
evaluating the noise level of a blank salmon, shrimp and tilapia muscle sample that had 
been analyzed and calculating the concentration equivalent to three times the noise 
expected at the retention time. 
Preliminary recoveries for all analytes were determined during method 
development to be 85 to 117% for tilapia, 85 to 106% for salmon and 95 to 110% for 
shrimp muscle. Preliminary method repeatability on tilapia muscle fortified at 5ng/g gave 
%RSDs of 3 to 8% depending on the analyte. All of these parameters were further 
investigated in validation. 
4.1.7 Ruggedness 
Ruggedness is defined as a resistance to changes in the results produced by an 
analytical method when minor deviations are made from the experimental conditions 
described in the method (Eurachem, 1998; CAC, 2009b). Ruggedness was investigated 
using tilapia muscle fortified to contain a concentration of 5 ng/g NI. Several variables 
tested were determined to have created statistically significant changes determined by a 
two sample t-test with p-values < 0.05 (Appendix 2).The factors which were found to be 
significant included the volume of acidic MeCN used; continued drying after evaporation 
was complete; evaporation temperature; and the filter used for collection of the final 
extract in the autosampler vial. The procedure was changed to include additional 
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specifications for the volume of acidic MeCN used and the evaporation temperature, as 
divergence from the required volume or temperature specified could significantly affect 
final results. Excessive drying during evaporation and the type of filter used were 
identified as critical control points, as divergence from the written method could severely 
affect final results. 
4.1.8 Internal Standard 
DMZ-D3 was introduced during method development as a quality control check 
for each sample analyzed in a run. The recovery of DMZ -D3 for each sample was first 
calculated during a method repeatability and recovery experiment. The recoveries 
calculated ranged from 86 to 97%. These recoveries were useful for determining any 
analyte loss in a particular sample during sample preparation or analysis. 
A deuterated internal standard is also commonly used in mass spectrometry to 
improve quantitative analysis, so the use of the internal standard for quantification was 
also investigated. In some cases, a single internal standard can be used for quantification 
of multiple analytes, provided the relative response factors of the analytes to the internal 
standard are well-established and recoveries of both the internal standard and the analytes 
are consistent. In many cases, however, it is preferable to use a deuterated version of each 
analyte as the internal standard for quantification of that analyte, since this eliminates the 
issues of recovery and consistency of response (it is generally considered that both 
analyte and deuterated internal standard will be subject to the same influences in any 
analysis, so recovery and response will be similarly affected for both). The use of the 
internal standard to improve quantification in this method is further discussed in Section 
4.2.2 Accuracy (Trueness and Bias). 
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4.1.9 Stability 
Stability testing of both analyte and analyte/matrix is a mandatory element for 
methods to meet the criteria of 2002/657/EC (EC, 2002). No degradation of analyte 
should occur during extraction, analysis or storage. It must be ensured that working 
standards are stable and a time period at which new ones must be prepared is established. 
It must also be determined if protecting the solution from light is required. In addition, 
stability in the presence of matrix has to be determined and can be combined with 
recovery experiments. To ensure sample stability, experiments are required to determine 
stability of the tissue during normal conditions of storage for a typical time period from 
sample receipt to analysis. It is necessary to use > 5 replicates for each concentration and 
time point in a sample stability study. 
4.1.9.1 Light Sensitivity 
Since nitroimidazoles had been reported as very light sensitive by Hurtaud et al. 
(2000) and were stored in the dark and/or in amber glassware in several other methods 
including Ho et al. (2005) and Xia et al. (2008), a mixed working standard was prepared 
and divided into two portions and one portion was stored under UV light to mimic 
potential exposure during routine use and the other in the dark. When neat standards were 
prepared with the UV-exposed and UV-protected working standard and the calibration 
curves compared, slope differences of < 10% were determined for HMMNI, IPZ, IPZ-
OH, MNZ and DMZ indicating no significant difference between the two sets of 
standards. The slope differences for MNZ-OH and RNZ were 11 and 15% indicating a 
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significant difference. Slope differences and calibration equations for all analytes are in 
table 4.8. A comparison of UV and non- UV calibration curves is shown in figure 4.10 for 
HMMNI. 
Table 4.8 Calibration equations and slope differences for calibration curves prepared with 
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Figure 4.10 Comparison of calibration curves prepared with UV-exposed and non UV-
exposed working standards for HMMNI 
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The two analytes, MNZ-OH and RNZ were further investigated by preparing ten 
20 ng/ml standards from both the light-protected and the UV-exposed working standard 
solutions. These were analyzed and the average area counts calculated for each. The 
%RSD was calculated between the two averages to be 5% for MNZ-OH and 1% for RNZ. 
Both of these were within previous instrument repeatability results. Therefore, it appeared 
that the analytes were not light sensitive in solution and did not require light protection. 
4.1.9.2 Standard Solution Stability 
Stability of analyte in solution was determined by comparing a working standard 
prepared on the day of analysis to one that had been stored in an amber vial in the dark at 
4°C. The %RSDs calculated between area counts of freshly prepared standards and 12-
month old standards were < 10% (table 4.9). These % RSDs remained within the range 
calculated during instrument repeatability. Therefore the working standard was 
considered stable under normal conditions of use for 12 months. 
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Table 4.9 Standard solution stability over 12 months: Comparison of old and freshly 


































































































4.1.9.3 Stability During Processing/Extract Stability 
To determine extract stability, the extracts from recovery studies were analyzed 
daily for 5 days. The mean concentration, SD and %RSD were calculated for each 
compound at the three concentration levels that had been used for the recovery studies (1, 
10 and 50ng/g). The mean concentration and SD from each day were plotted on graphs to 
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determine if the error bars overlapped from each time point. CUSUM charts, t-test and 
ANOVA were also used to detect any changes in the extracts. 
When the average results from the 5 day stability study for the lng/g 
concentration were plotted for all analytes, the ranges encompassed by the error bars 
overlapped one another. For DMZ at lOng/g, the day 4 error bar was not within the range 
of any other error bar; however at day 5 it was back within the range at day 3. All others 
were within the range of one another at lOng/g. At 50ng/g, a few error bars were out of 
range, but they were back in the range of the initial time point at the following time point. 
From these graphs, all analytes in the extracts appeared stable for 5 days. See figure 4.11 
for HMMNI graphs and Appendix 3 for all other analytes. The differences observed were 


























Figure 4.11 Charts representing tilapia muscle extract stability of HMMNI over 5 days at 
lng/g (a), 10 ng/g (b) and 50 ng/g (c) 
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A CUSUM chart is a statistical tool used to monitor change (Page, 1954; Barnard, 
1959). A CUSUM chart is constructed to show trends in change, so that random positive 
and negative changes in the quantity being monitored are expected. However, when the 
changes are consistently positive or negative and proceed outside the control limits 
established for the process, then the process is considered to be "out of control". In this 
case, where changes in concentration over time were being monitored, a continued 
decrease (or increase) in concentration of analyte from the concentration measured at the 
initial time point would suggest instability of the analyte or sample material. 
From plotting CUSUM charts (figure 4.12 for HMMNI and Appendix 4 for all 
other analytes), which were used to reveal any changes in concentration of analyte in the 
extracts over the 5 days, a few points were found outside of the control limits, but all with 
the exception of one were back in on day 5. MNZ at lOng/g was out on day 5, however 
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Figure 4.12 CUSUM charts representing stability of HMMNI in tilapia muscle extract 
over 5 days at lng/g (a), lOng/g (b) and 50ng/g (c) 
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The t-tests applied to the extract results showed there were significant differences 
between time 0 results and some of the other time points with p-values < 0.05. When 
results at each time point were compared with one another for an analyte at a particular 
condition/concentration using ANOVA, significant differences were also seen. Some F 
statistics were determined to be larger than the critical F values. The %RSDs calculated 
on the results from the 5 days for each analyte at all concentrations were within the 
acceptability limits for repeatability of the method indicating the extracts were stable. The 
mean, SD and RSD are shown in table 4.10. The raw data and examples of t-tests and 
ANOVA are in Appendix 5. Since the t-test and ANOVA findings contradicted what was 
shown by %RSD and CUSUM, it was considered that the data sets used may not have 
been large enough to apply t-tests or ANOVA and the results do not prove instability of 
the analytes. Some authorities require 20 fish replicates per time point. In addition, no 
recovery losses attributable to analyte instability were observed during method 
development and validation experiments. 
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Table 4.10 Mean, SD and %RSD for stability of NI analytes in tilapia muscle extract 


































































































4.1.9.4 Tissue Stability 
The stability of the analytes in tissue was determined by analysing tilapia muscle 
samples fortified at 1.5 and lOng/g NIs and stored for 2 months at -20°C and -80°C. The 
material stored at -20°C included both pre-weighed samples and containers of sample 
which had to be thawed to take a portion for testing and refrozen to mimic how samples 
are typically treated in the lab. The samples stored at -80°C were pre-weighed. The mean, 
SD and %RSD was calculated for 5 replicates at each biweekly time point for 2 months at 
each concentration and condition studied. In addition, error bar and CUSUM charts were 
prepared and t-tests and ANOVA were used to determine changes in the tissue 
concentration. 
On all graphs where the average of the results from 5 replicates over a 2 - month 
period at each time point was plotted with error bars for each analyte and condition, the 
error bars were within the range of one another for 1.5 and lOng/g tissue. See figure 4.13 
and 4.14 for HMMNI at 1.5 and lOng/g, respectively and Appendix 6 and 7 for all other 
analytes. From this, all analytes were considered stable in tissue for 2 months under the 
tested conditions. When CUSUM charts were used to display running totals of the 
differences in results from the average at time 0, a few points were slightly outside the 
control limits, but none were below the lower control limit indicating there had been no 
degradation. Figure 4.15 shows results for 1.5 ng/g HMMNI and figure 4.16 shows 
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Figure 4.13 Error bar charts representing the stability of HMMNI in tilapia tissue over a 
2 month period at a concentration of 1.5 ng/g with storage conditions of -20°C (a), -80°C 
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Figure 4.14 Error bar charts representing the stability of HMMNI in tilapia tissue over a 
2 month period at a concentration of 10 ng/g with storage conditions of-20°C (a), -80°C 
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Figure 4.15 CUSUM charts representing the stability of HMMNI in tilapia tissue over 2 
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Figure 4.16 CUSUM charts representing the stability of HMMNI in tilapia tissue over 2 
months for 10 ng/g at storage conditions of -20°C (a), -80°C (b) and -20°C freeze/thaw (c) 
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As with extract stability, t-tests and ANOVA applied to the results indicated some 
significant differences between time points, but data sets were not large enough. The % 
RSDs calculated for each analyte at the different conditions and concentrations were 
typical of those seen in validation repeatability studies. Therefore, analytes were stable at 
the conditions and concentrations studied. The mean, SD and % RSD are summarized in 
table 4.11, 4.12 and 4.13 for tissue stability at -20°C, -80°C and -20°C freeze/thaw, 
respectively. The raw data for tissue stability is shown in Appendix 10. 
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Table 4.11 Mean, SD and % RSD for tilapia tissue stability of NI analytes for 1.5 and 10 






































































Table 4.12 Mean, SD and % RSD for tilapia tissue stability of NI analytes for 1.5 and 10 






































































Table 4.13 Mean, SD and % RSD for tilapia tissue stability of NI analytes for 1.5 and 10 






































































4.2 Method Validation 
4.2.1 LOD and LOQ 
LOD was determined for each analyte in tilapia, salmon and shrimp muscle by 
first measuring the height of the noise level in 20 blank samples (5 extracts/day over 4 
days) in the quantifying chromatogram at the expected retention times for each analyte 
and calculating the concentration equivalent to the noise. The tissue concentration at 
instrument noise was averaged for each analyte and multiplied by 3 to give LODs ranging 
from 0.07 to 0.32 ng/g for tilapia, 0.08 to 0.41 ng/g for salmon and 0.08 to 0.24ng/g for 
shrimp, depending on the analyte. The LOQ was calculated by multiplying the LOD by 3 
and ranged from 0.20 to 0.97 ng/g for tilapia, 0.24 to 1.2 ng/g for salmon and 0.23 to 0.74 
ng/g for shrimp. 
It was later realized that some LOD results were underestimated and the 
confirmation ion could not be seen at these levels. The LOD values had to be adjusted in 
order for confirmation to be achieved at the claimed LODs. Adjusted values included 
0.40 ng/g for HMMNI, 0.30 ng/g for RNZ and 0.20 ng/g for DMZ in tilapia muscle; 1.0 
ng/g HMMNI in salmon muscle; and 0.90 ng/g for HMMNI, 0.20 ng/g for RNZ and 0.10 
ng/g for DMZ in shrimp muscle. LOQ values were also adjusted as necessary. It was 
decided the noise level of the confirmation chromatogram would be used for determining 
LOD to avoid this problem in the future. LOD and LOQ for tilapia, salmon and shrimp 
muscle including adjusted values are shown in tables 4.14. Raw data can be found in 
Appendix 11. 
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4.2.2 Accuracy (Trueness and Bias) 
The fortification levels chosen for recovery studies were 1,10 and 50 ng/g in 
tilapia, salmon and shrimp muscle for all analytes. This was based on 3 X LOD (LOQ), 
10 X LOD and the upper limit of the linear range (CAC, 2009b). LOQs varied depending 
on the analyte, therefore to simplify the method recovery experiment, concentrations were 
chosen based on the average of the LOQs. For example, lng/g was chosen for LOQs 
ranging from 0.2 to 3.0 ng/g for all analytes and matrices studied. Also, 50ng/g was 
chosen as the upper limit of the linear range even though the calibration curve was linear 
at higher concentrations because this was the range to be worked in during routine testing. 
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In tilapia muscle at a concentration of lng/g, average recoveries for analytes 
ranged from 97 to 124%). At lOng/g, recoveries were seen from 95-122%) and for 50ng/g 
results were 89-118%. For salmon muscle, recoveries were 94-123% at 1 ng/g; 87-119% 
at lOng/g; and 81-119%) at 50ng/g. Recoveries achieved from shrimp muscle were 98-
124% at lng/g, 93-118% at lOng/g and 93-110% for 50ng/g. Most recoveries were 
greater than 100%, indicating positive biases, while only a few were less than 100% 
(indicating negative bias). 
The performance criteria that should have been met in recovery studies included 
the following: a range of mean % recovery from 60-120% for concentrations from 1 to 10 
ng/g and 70-110%) for 50 ng/g (CAC, 2009b). Recovery results for shrimp muscle met the 
criteria for all analytes at all concentrations. For salmon muscle, three analytes, HMMNI 
(117%), MNZ (119%) and RNZ (111%) were out of range at 50 ng/g. Average IPZ-OH 
recovery of 118% was also out of range at 50ng/g for tilapia. These criteria were 
established for single analyte methods and therefore in a multi-analyte method these 
deviations were considered acceptable because conditions cannot be optimized for all 
individual analytes in a multi-analyte method. Use of appropriate ISs could bring 
performance of these analytes within the accepted criteria. 
In an attempt to improve recoveries, they were corrected using the DMZ-D3 IS by 
calculating a peak area ratio of analyte or standard response divided by IS area response 
to calculate recoveries. This allowed recoveries for tilapia and shrimp muscle to meet the 
criteria, but salmon muscle still had analytes out of the % recovery range, including 
HMMNI (120%), IPZ (111%) and IPZ-OH (112%) at 50ng/g. It appears correcting all 
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analytes using DMZ-D3 as an IS may not be an improvement. This is further discussed in 
section 4.2.3. 
The percent recoveries were also calculated for DMZ-D3 spiked at 2.5ng/g in all 
matrices. DMZ-D3 in tilapia muscle had a mean recovery of 103% while the average 
recovery was 105% and 118% for salmon and shrimp muscle, respectively. These 
recoveries met the performance criteria. Mean recoveries for each concentration tested 
including IS corrected mean recoveries for all analytes are summarized in tables 4.15 for 
tilapia muscle, 4.16 for salmon muscle and 4.17 for shrimp muscle. See Appendix 12 for 
more detailed raw recovery data. 
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Table 4.15 Accuracy for NI analytes including mean recovery, IS corrected recovery, SD 

















































































































































































Table 4.16 Accuracy for NI analytes including Mean recovery, IS corrected recovery, SD 

















































































































































































Table 4.17 Accuracy for NI analytes including Mean recovery, IS corrected recovery, SD 


















































































































































































Instrument repeatability was determined by repeat injections of standards from the 
calibration curve and fortified samples at 1, 10 and 50ng/g concentrations. A summary of 
%RSD for the standards is provided in tables 4.18, 4.19 and 4.20 for tilapia, salmon and 
shrimp muscle tissues, respectively. The % RSD for repeat injections of fortified samples 
of tilapia, salmon and shrimp muscles are in tables 4.21, 4.22 and 4.23, respectively. For 
all analytes in tilapia muscle, % RSDs were < 10% which was considered to be within 
acceptable limits. For salmon muscle, all analytes had % RSDs < 10%, except for MNZ-
OH and RNZ, which had < 15%. Shrimp muscle was similar to salmon muscle, having a 
%RSD for MNZ-OH as high as 18% and 11% for RNZ. Since the method was a multi 
analyte method, making less scans available per analyte, these repeatabilities were 
accepted. More work on the MS was planned to improve the repeatability for these 
analytes. It was also discovered that running certain other veterinary drug methods prior 
to nitroimidazole analysis on the same column affected repeatability. Methods such as 
CFIA SOM-DAR-CHE-050-01, 2009 (fluoroquinolones) and SOM-DAR-CHE-039-07, 
2009 (triphenylmethane dyes), which use different mobile phases, caused the instrument 
response of standards to increase during an analytical run. In response to this issue, a 
column was designated for nitroimidazole analysis only. 
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Table 4.18 Instrument repeatability determinations (%RSD) of NI analytes in 










































Table 4.19 Instrument repeatability determinations (%RSD) of NI analytes in 










































Table 4.20 Instrument repeatability determinations (%RSD) of NI analytes in 










































Table 4.21 Instrument repeatability determinations (%RSD) of NI analytes in 


































Table 4.22 Instrument repeatability determinations (%RSD) of NI analytes in 


































Table 4.23 Instrument repeatability determinations (%RSD) of NI analytes in 



































Tilapia, salmon and shrimp muscle tissues fortified at 1, 10 and 50 ng/g were 
analyzed to determine method repeatability expressed as %RSD. Uncorrected data were 
first used to calculate %RSD followed by data corrected by spike recovery. Results for 
tilapia muscle are summarized in table 4.24, results for salmon muscle are in table 4.25 
and results for shrimp muscle are in table 4.26. See Appendix 13 for raw data. The 
criteria used to determine the performance of an analytical method were derived from a 
statistical evaluation of data from several thousand collaborative studies (CAC, 2009b). 
The performance targets for precision recognized by Codex Alimentarius were < 35% for 
concentration of lng/g, 30% for lOng/g and 20%) for 50ng/g. The %>RSD results for all 
analytes at each concentration in salmon and shrimp muscle tissues were within the target 
limits for both uncorrected and corrected data. In tilapia muscle tissues, the % RSD from 
uncorrected data for RNZ was the only result higher than the criteria at 21%> for 50ng/g. 
However, the % RSDs calculated with the corrected data were within the criteria limits. 
Since the CAC recommends recovery-corrected data should be reported (CAC, 2009a), 
the results were considered acceptable for tilapia. 
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Intermediate precision was calculated from results generated by 2 analysts. The 
%RSDs for intermediate precision were expected to be 1-2% greater than those for a 
single analyst, as different analysts will typically have minor differences in the manner in 
which they perform the method. These results were also calculated based on both spike 
corrected and uncorrected data. All of the %RSDs for tilapia and shrimp were within the 
acceptability criteria. Salmon had a %RSD of 24% for IPZ at 50ng/g with uncorrected 
data, which was above the target limit. The % RSDs from the corrected data were within 
the target limits and therefore intermediate precision criteria were considered to be met. 
HorRat values were also calculated for intermediate precision. The HorRat is the 
ratio of the reproducibility relative standard deviation to that calculated from the Horwitz 
equation (Horwitz & Albert, 2006; CAC, 2009b). The HorRat is indicative of method 
performance for a large majority of analytical methods in chemistry. Typical limits of 
HorRat acceptability are between 0.5 to 2.0 for between laboratory performance. The 
within laboratory RSD (repeatability) is typically one-half to two thirds of the between 
laboratory RSD, therefore HorRat acceptability limits of 0.3-1.3. The HorRat values 
calculated for salmon muscle were all within these acceptability limits for both 
uncorrected and spike corrected data. Values for shrimp and tilapia muscle were < 1.3 and 
some were biased low for acceptability limits (<0.3). This was believed to be due to the 
fact that the analysis done by different analysts was done on the same instrument. It is 
recognized that within-laboratory results for the HorRat may fall below the accepted 
range and this is usually attributed to good quality control of the analytical process, 
including factors such as analyst training and experience, use of dedicated analytical 
instruments and common reagents, etc., within the laboratory (Horwitz & Albert, 2006). 
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Salmon muscle had the higher HorRat values because the fortified salmon used by the 
second analyst was past the determined stability time and lower concentrations resulted. 
The degraded results were confirmed by a re-analysis of the tissues by analyst 1 at that 
time. A comparison of these results with % RSDs between the two sets of data are shown 
in table 4.27. Intermediate precision results are summarized in tables 4.28, 4.29 and 4.30 
for tilapia, salmon and shrimp muscle respectively. The raw data results are in Appendix 
13. 
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Table 4.28 Intermediate precision results including combined mean, RSD and HorRat values from uncorrected and spike corrected 






















































































































































































































Table 4.29 Intermediate precision results including combined mean, RSD and Horat values from uncorrected and spike corrected 






















































































































































































































Table 4.30 Intermediate precision results including combined mean, RSD and HorRat values from uncorrected and spike corrected 






















































































































































































































Method repeatability %RSD was also calculated for concentrations corrected with 
the IS DMZ-D3 area counts and are shown in table 4.31 for tilapia muscle, table 4.32 for 
salmon muscle and table 4.33 for shrimp muscle. The raw data can be seen in Appendix 
13. These % RSDs for each commodity and concentration for all analytes were within the 
acceptable criteria. This was an improvement over the previous repeatability results from 
both corrected and uncorrected data. However, it was also noted that DMZ-D3 did not 
appear appropriate to correct results for all analytes. In particular, IPZ-OH concentration 
results appeared to be overestimated. These results were similar to uncorrected results and 
higher than spiked corrected values. It was determined that DMZ-D3 could not be applied 
to all analytes studied as an IS and further work is required with more internal standards. 
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4.2.4 CCa and CCp 
The decision limit (CCa) is determined by using validation guidelines provided by 
the EU. Commission Decision 2002/6576EC, which sets guidelines for the validation of 
both screening and confirmatory analytical methods of analysis. The Commision 
Decision implements the Council Directive 96/23/EC concerning the method 
performance and interpretation of results, for the fulfillment of key requirements set by 
the EU. The directive applies not only to methods used by official regulatory laboratories 
for control of veterinary drug residues in foods within the EU, but also to laboratories 
conducting tests in other countries for foods to be exported to the EU. Performance 
characteristics such as detection capability must be assessed in order to classify a 
screening method as "fit for purpose"; i.e., capable of detecting and quantifying residues 
of a particular analyte. For the method to be classified as confirmatory, the decision limit 
must also be included in validation studies. 
The decision limit was determined simultaneously with LOD as these are 
determined in the same manner for analytes such as the NIs which have no maximum 
residue limits set. The decision limits ranged from 0.07 to 1.0 ng/g depending on the 
analyte and matrix. Appendix 11 contains the raw data for CCa. These levels were used 
to spike the appropriate blank material to be analyzed. The SD of the concentration of 
samples was determined and used to calculate the CCp. Both uncorrected and spike 
corrected results were used to calculate CCp. In tilapia muscle, the CCP ranged from 0.09 
to 0.49 ng/g using uncorrected data and 0.09 to 0.50 ng/g using spike corrected data. For 
salmon muscle, uncorrected data gave CCP ranging from 0.11 to 1.15 ng/g and spike 
corrected from 0.10 to 1.14ng/g. Shrimp muscle had CCp values for uncorrected data 
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from 0.11 to 1.02 ng/g and 0.11 to 1.03 for spike corrected. CCP results were not affected 
by using uncorrected versus spike corrected results. Results were summarized in tables 
4.34, 4.35 and 4.36 for tilapia, salmon and shrimp muscle, respectively. See Appendix 14 
for CCP raw data results. 
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Table 4.34 CCa and CCP using uncorrected and corrected spike results obtained for NI 



































Table 4.35 CCa and CCp using uncorrected and corrected spike results obtained for NI 




































Table 4.36 CCa and CCP using uncorrected and corrected spike results obtained for NI 



































4.2.5 Measurement Uncertainty (MU) 
ISO/IEC-17025 requires that an accredited lab assess the MU associated with each 
test method listed within the scope of the accreditation. This was included as part of the 
validation for the NI method. It included both accuracy (the closeness of the result to the 
true value) and precision (the variability associated with measurement). The "top down" 
approach was taken which used a direct determination of the combined contributions of 
uncertainty from method performance obtained during recovery studies and method 
precision (Ellison et al, 2000). 
It would be expected that the MU for an analytical method for food analysis 
would be approximately 20-50% at the 95% confidence interval (k=2). MUs were 
calculated using both uncorrected and spike corrected data for intermediate precision. 
Results are summarized in table 4.37. For tilapia muscle, the MUs using uncorrected 
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results were within 20-50% accept for RNZ which was 60%. The MU for RNZ was 28% 
using corrected results, however IPZ was 57%). All other MUs with corrected results were 
within 20-50%) for tilapia. MUs (uncorrected results) for shrimp muscle ranged from 36-
40%, except for IPZ which was at 60%, while MUs (corrected results) were 34-45% 
except for RNZ which was 66%. All MUs for salmon muscle were higher than the 
expected range. The uncorrected result MUs ranged from 58-82% and the corrected from 
55-81%. This was because of the increased %RSDs for intermediate precision due to the 
fortified salmon material degrading. Future experiments with IS should improve % RSDs 
for recovery and precision as well and therefore improve MU. 
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4.3 Depletion Study 
The application for an Experimental Studies Certificate (ESC) for the use of MNZ 
was reviewed by the Clinical Evaluation Division (CED) and the Human Safety Division 
(HSD) of Health Canada and it was deemed to be unnecessary to obtain an ESC for MNZ 
to be used in the depletion study. The online Experimental Fish Course by the Canadian 
Aquaculture Institute was successfully completed and the Animal Use Protocol was 
approved by the Animal Care Committee. The Letter of Understanding (LOU) was signed 
by both parties and security clearance was given for CFIA employees involved in the 
project to enter BIO to perform duties related to the depletion study. 
4.3.1 Preparation of Medicated Diet 
To account for residue loss during preparation of the medicated feed, a 10% 
excess of MNZ was added. Therefore, 3.3g of MNZ was added to 1kg of feed to get a 
concentration of approximately 3g/kg. It was determined that 4mls of acetone should be 
added per lOg of pellets for optimal absorption by the pellets. Therefore, 3.3g of MNZ 
was absorbed in 400ml of acetone for 1kg of feed. 
The analysis of medicated feed was done in triplicate with three medicated pellet 
sample extracts being diluted 106 times and another 3 samples being diluted 105 times. 
Non-medicated pellet samples spiked at 3g/kg were also done in triplicate with 10 and 
10 dilutions. Results are summarized in Table 4.38. The average concentration was 
determined to be 2.8g MNZ per kg of feed (RSD 5.6%) with an average spike recovery of 
104%. 
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4.3.2 Preparation of Incurred Fish 
The fish were delivered by the Nova Scotia Provincial Government fish hatchery 
in Caledonia, NS on Sept 7, 2010 and placed in the holding tanks to be used for the 
depletion study at BIO. Fish were not fed on the first day of arrival as they were expected 
not to eat when stressed from travel. After that, they ate well each day during the 20-day 
acclimatization period at 1 % of their body weight/day. A mortality was found on day 8 
after arrival. Water temperature was recorded each day at approximately 9:00 am by the 
Fish Laboratory Manager at BIO and the temperatures are shown in table 4.39 and figure 
4.17 for the entire study including the acclimatization period. The mean temperature with 
SD from the day the fish arrived to the end of the depletion study was 18.2 ± 1.3 °C. The 
mean temperature from the first day of medication to the last day of withdrawal was 
17.4±0.94°C. 
137 













































































15 i l l , , , , , , r — T - , i 
# ^ ^ <f 4? # # <# /" ^ *< #* , / ^ ^ ^ ^ N̂ ° /> , / /> . / 
Date 
Figure 4.17 Daily Temperatures recorded during acclimatization and the depletion study 
4.3.3 Sampling of Fish 
On day 14 after the fish arrived, 7 control samples were taken. Since there was a 
larger range in the size offish than anticipated, it was decided to take seven of the larger 
fish rather than random sampling so the depletion study would be done on fish closer in 
size. After sampling fish were measured and weighed. Mean weight and length with SD 
are summarized for each time point in table 4.40. All weights and lengths recorded are in 
Appendix 15. The remaining fish were given medicated feed at 1 % their body 
weight/day for the first 5 day medication period taking samples on the scheduled days. 
Withdrawal was originally to be 10 days, however fish were mistakenly fed medicated 
feed on the sixth day of withdrawal. It was then decided to do the second 5 day 
medication period with a 16 day withdrawal period. There were enough fish remaining to 





period. Four fish remained after all samplings which were sacrificed and used as quality 
control material. 
































































4.3.4 Chemical Analysis 
It is beneficial to test a method for detection of veterinary drug residues using 
actual dosed animal (incurred) samples as these samples are closer to what would be 
found in an actual monitoring situation than samples which have only been fortified 
(Maher et al, 2008). This was accomplished as a result of the depletion study as well as 
providing knowledge to enable interpretation of residue findings during routine analysis. 
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Each sample taken for each time point was analyzed for MNZ along with its 
metabolite MNZ-OH in duplicate and the mean, SD and % RSD were calculated. The 
results obtained for MNZ are in table 4.41 and table 4.42 for MNZ-OH for the first 
medication and withdrawal period. For the second withdrawal period, MNZ results are in 
table 4.43 and MNZ-OH results are in table 4.44. Raw data are shown in Appendix 16. If 
the %RSD for duplicates fell outside of typical method repeatability (>25%), the analysis 
was repeated. The results for all samples at each time point were also averaged and the 
SD and %RSD calculated. The mean results for the first medication and withdrawal 
period are in table 4.45 and the results for the second withdrawal period are in table 4.46. 
There were large ranges with high % RSDs between samples from the same time point. A 
Grubb's test was done to determine any outliers (Appendix 17). Only one result was 
found to be an outlier and the analysis was repeated. The range of results was expected 
due to the nature of working with live animals. The fish were the same age, but ranged in 
size and fed and metabolized the drug at different rates. Even though results from the 
same time points varied, an overall increase in concentration of MNZ and MNZ-OH was 
seen during the first medication period and a decrease during the withdrawal periods. The 
concentration of MNZ can be seen in figure 4.18 for the first medication and withdrawal 
period while the concentration of MNZ-OH is shown in figure 4.19. The depletion of 
MNZ and MNZ-OH during the second withdrawal period can be seen in figures 4.20 and 
4.21, respectively. 
141 




















































































































































































































































































































































































































































































































Table 4.45 Mean concentrations of residues of MNZ and MNZ-OH in muscle of trout treated with MNZ during the first medication 











































329 ± 82 
764 ± 464 
































20346 ± 5670 
1058 ±613 
165 ±188 
51 ± 81 
2 ± 2 







































0.00 Time (days) 
Figure 4.18 Depletion curve representing MNZ concentrations in trout tissue 
during the first MNZ medication and withdrawal period. 
Time (days) 
Figure 4.19 Depletion curve representing MNZ-OH concentrations in trout tissue 




Figure 4.20 Depletion curve representing MNZ concentrations in trout tissue 
during the second withdrawal period. 
900 
Time (days) 
Figure 4.21 Depletion curve representing MNZ-OH concentrations in trout tissue 
during the second withdrawal period. 
No residues were detected before the medication period and low concentrations of 
drug residues were still detectable after 16 days of withdrawal. The mean MNZ residue 
concentration peaked on day 1 of withdrawal at 27425 ± 10262 ng/g during the first 
study. MNZ-OH residue concentration also peeked on day 1 of withdrawal with a 
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concentration of 832 ± 573 ng/g. On day 5 of withdrawal the MNZ residue level was 
3617 ± 2963 ng/g and MNZ-OH was 246 ±156 ng/g. During withdrawal after the second 
medication period, the residue level was 20345 ± 5670 ng/g for MNZ on day 1 and MNZ-
OH was 552 ± 242 ng/g. By day 16 of withdrawal, the MNZ concentration was 1.8 ± 2.3 
ng/g and MNZ-OH was below the LOD (<0.40). 
MNZ and MNZ-OH were detected in relatively high concentrations during the 
medication periods. As a result extracts from the samples were diluted appropriately in 
order for the drug levels to fall within the range of the calibration curve for the method. 
The values reported were corrected for these dilutions. The highest results obtained were 
5 to 10 times higher than previous depletion studies seen (Maher et al, 2008 and Sorenson 
and Hansen, 2000). However, the trout in the study conducted by Sorenson and Hansen 
were fed a much lower dose of MNZ (approximately 6 times lower). In the Maher study, 
the dose was comparable, but it was a different species of fish (tilapia) so different results 
would be expected, especially considering the differences in fat content. 
The fraction of MNZ-OH to MNZ was reported as less than 2 % on the first day 
after the administration period in the study by Sorensen and Hansen, 2000. The results 
observed in the Maher et al (2008) study were similar. In this study, on day 3 of the first 
medication period the fraction of MNZ-OH to MNZ was less than 2% as well, but it 
increased as the study continued and was 6.8% by day 10 of withdrawal. During the 
second withdrawal period, the level started at 2.7% on day 1 and increased as high as 
13.8% on day 9 of withdrawal. Fractions of MNZ-OH to MNZ at each time point can be 
seen in table 4.45 for the first medication and withdrawal period and in table 4.46 for the 
second withdrawal period. 
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4.3.5 Tissue Disposal 
The incurred tissue that remained after chemical analysis for the depletion study 
was stored at -80°C. All incurred tissue material was combined and diluted with the blank 
control material to obtain appropriate levels to be used for quality control materials 
during routine residue testing. 
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SUMMARY AND CONCLUSIONS 
Chemical usage is widespread in the aquaculture industry. Nitroimidazoles are a 
class of veterinary drug that have been banned for use in food producing animals, 
including aquacultured fish, due to safety concerns. Residue testing for nitroimidazoles 
was identified as a priority by the CFIA to meet EU requirements for exports. To meet 
this requirement, a thesis project to develop and validate a residue method was 
undertaken and completed. 
For project completion several objectives had to be satisfied. A review of 
available information on analytical methods for nitroimidazole residues and depletion 
studies in fish was completed. Limited information was found on nitroimidazole residues 
in fish. However, using the information and resources available, a simple, rapid and 
sensitive quantitative and confirmatory method was developed and validated that is 
suitable for monitoring of nitroimidazole residues and their hydroxy metabolites in fish 
tissue using UPLC-MS-MS. Good recoveries (87-121%) and acceptable RSDs (<26%) 
for method repeatability were obtained with low limits of quantitation, (0.21-3.0 ng), 
depending on the analyte. Working standards were determined to be stable for 12 months, 
while extracts were stable for 5 days and tissue for 2 months under appropriate storage 
conditions. The validated method meets performance requirements for use in a regulatory 
monitoring program for nitroimidazole residues in fish and crustaceans. 
Since few reports had been published on the metabolism of nitroimidazoles in 
fish, a depletion study was undertaken using MNZ in feed provided to trout under 
controlled conditions. The effectiveness of the method was further shown by its 
determination of MNZ and MNZ-OH levels in the incurred trout fish muscle tissue. 
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Analyte concentrations were determined over a 5 day medication and 16 day withdrawal 
period. This information from the depletion study will enable interpretation of residue 
findings during regulatory monitoring. 
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FUTURE WORK 
Although a method for the determination of NIs in fish and crustaceans was 
developed and validated for salmon, tilapia and shrimp muscle and MNZ and its 
metabolite were successfully analyzed in incurred trout material, challenges still remain. 
Future work including the investigation of the use of ISs and/or improved SPE clean up to 
eliminate matrix effects are recommended to deal with these challenges. 
Ion suppression was identified for all compounds in the matrices studied. To 
correct for these matrix effects, a matrix matched calibration curve was used to quantitate 
analytes. However, it has been found that the degree of ion suppression/enhancement 
varies from matrix to matrix and also between different lots of the same sample 
(Matusweski et al., 2003). In a regulatory environment several different matrices may 
need to be analyzed in the same run. Salmon, shrimp and tilapia muscle are representative 
of many samples the CFIA analyzes, but many other species and processed samples 
require analysis as well. In addition, if different sources of the same matrices demonstrate 
different degrees of ion suppression or enhancement, as found by Matusweski, this would 
create a problem for matrix matched calibration. 
The addition of an internal standard is largely used to compensate for matrix 
effects (Gosseti et al., 2010). In particular, the use of stable isotope-labelled analogues as 
ISs is highly recommended for diminishing suppression effects. These were not used for 
the method validation due to their expense. However, with the knowledge that the NI 
compounds studied are stable in solution for at least a year, it makes their purchase more 
feasible. Also, considering an increase over the last 2 years in the variety of matrices that 
154 
require regulatory testing, future work with ISs is recommended to diminish matrix 
effects. 
Matrix effects may also be eliminated or minimized by modifications to the clean 
up process (Matusweski et al., 2003 and Gossetti et al, 2010). To lower matrix effects in 
the final extract, it is suggested to systematically determine the matrix effect after 
different sample pre-treatments. Strong cation exchange (SCX), OASIS HLB and more 
recently molecularly imprinted polymers (MIP) have been used to clean up extracts for 
NI analysis. Experiments utilizing various SPE clean up alternatives are recommended. 
Since the NI method follows several of the steps of other established methods for 
other classes of veterinary drugs such as triphenyl methane dyes and fluoroquinolones, 
the possibility exists for the development of a multi-class residue method. Maximizing 
the number of analytes that may be determined by a single procedure or from a single 
portion of test material would be more cost-effective (Stolker et al, 2008). There is 
increasing interest in methods for the simultaneous analysis of several classes of 
veterinary drugs. Very few multi-class LC-MS-MS methods exist due to a number of 
analytical challenges to overcome. However, due to cost-effectiveness and time saving 
possibilities, investigation of the multi-class residue approach is therefore recommended 
as a potential area for future work. 
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Appendices 
Appendix 1 Comparison of hexane wash results with acetonitrile extract (analysis 1) and 0.1% acetic acid make up solvent (analysis 
2) salmon and shrimp muscle at low, medium and high concentrations for all analytes. Also included is an example of a paired t-test 
for HMMNI in each commodity. 
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t Critical one-tail 
P(T<=t) two-tail 






















































































































































































































































































































































































































Example oft-test for salmon muscle HMMNI results: 
HMMNI 












t Critical one-tail 
P(T<=t) two-tail 





















































































































































































































































































































































































































































































































































































































































































































































































































































































































Example oft-test for shrimp muscle HMMNI results: 
HMMNI 











t Critical one-tail 
P(T<=t) two-tail 























































Appendix 2 Experimental results and calculations for ruggedness testing using tilapia muscle. An example of the full calculations 
including a t-test is given for HMMNI. For all other analytes (IPZ, IPZ-OH, MNZ, MNZ-OH, RNZ and DMZ) only experimental data 
results are shown. 
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Two sample t-tests for ruggedness: 
HMMNI 
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Appendix 3 Error bar charts representing tilapia muscle extract stability of NI analytes 
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Appendix 4 CUSUM charts representing stability of NI analytes in tilapia muscle extract 
over 5 days at lng/g (a), 10 ng/g (b) and 50 ng/g (c). 
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Appendix 5 Data from tilapia muscle extract stability (low, medium and high 
concentrations) with examples of a t-test and ANOVA for HMMNI at low concentration. 




























































































































































































































































t Critical one-tail 
P(T<=t) two-tail 



































































































Source of Variation SS ctf MS F P-value F crit 
Between Groups 0.164824 4 0.041206 3.604444 0.022780322 2.866081 
Within Groups 0.22864 20 0.011432 
Total 0.393464 24 
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Appendix 6 Error bar charts representing the stability of NI analytes in tilapia tissue over 
a 2 month period at a concentration of 1.5 ng/g with storage conditions of-20°C (a), -
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Appendix 7 Error bar charts representing the stability of NI analytes in tilapia tissue over 
a 2 month period at a concentration of 10 ng/g with storage conditions of-20°C (a), -80°C 
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Appendix 8 CUSUM charts representing the stability of NI analytes in tilapia tissue over 
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Appendix 9 CUSUM charts representing the stability of NI analytes in tilapia tissue over 
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Appendix 10 Data from tilapia tissue stability for -20°C, -80°C and -20°C freeze/thaw 
conditions at concentrations of 1.5ng/g and 1 Ong/g. An example of a t-test and ANOVA 
is included on results for 1.5ng/g HMMNI at -20°C. 




























































































































































































































































t Critical one-tail 
P(T<=t) two-tail 




































































































Source of Variation SS df_ MS F P-value F crit 
Between Groups 0.582904 4 0.145726 12.78522548 2.52534E-05 2.866080706 
Within Groups 0.22796 20 0.011398 
Total 0.810864 24 
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1320 670 1250 1250 1070 
0 059 0 031 0 057 0 059 0 053 
4640 2610 2420 1840 4140 
0 123 0 072 0 066 0 051 0 121 
1710 410 1070 926 1020 
0 069 0 017 0 044 0 039 0 045 
862 1840 775 1570 1740 
0 124 0 276 0 114 0 237 0 274 
3490 1920 2320 3920 1940 
0 177 0 102 0 121 0209 0 111 
2480 3120 1490 1940 2330 
0 076 0 100 0 047 0 063 0 079 
1700 2250 1430 2800 3210 
0 111 0 140 0 089 0 183 0 208 
984 909 965 836 918 
0 026 0 023 0 024 0 022 0 023 
3004 3030 3380 2780 2830 
0 078 0 075 0 084 0 073 0 071 
813 778 522 538 569 
0 028 0 026 0 017 0 019 0 019 
900 1530 1080 1010 736 
0 098 0 158 0 112 0 110 0 077 
2210 1590 2350 2470 2730 
0 151 0 104 0 154 0 169 0 179 
1360 1480 1200 1090 1010 
0 029 0 030 0 024 0 023 0 020 
2020 1810 1770 1930 1630 
0 174 0 158 0 149 0 164 0 145 
1230 857 1220 767 816 
0 049 0 034 0 047 0 030 0 033 
5340 4950 1980 3200 5140 
0 134 0 126 0 049 0 079 0 133 
916 558 828 872 728 
0 025 0 016 0 022 0 024 0 021 
1370 1570 1150 1220 1260 
0 149 0 173 0 122 0 131 0 141 
3170 2650 4470 3500 2810 
0 149 0 126 0 206 0 163 0 136 
1640 1580 1270 1370 1200 
0 043 0 042 0 033 0 036 0 033 
1740 1610 1340 1470 2710 
0 087 0 079 0 068 0 069 0 136 
758 579 506 453 475 
0 081 0 061 0 055 0 046 0 051 
5222 4240 3460 4030 4290 
0 062 0 049 0 042 0 045 0 051 
1050 1120 1140 718 1630 
0 019 0 020 0 021 0 012 0 030 
1190 1140 599 867 1560 
0 084 0 079 0 043 0 061 0 110 
3360 3670 2350 3990 4180 
0 091 0 097 0 065 0 102 0 114 
2050 2260 1380 1100 1060 
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1420 1460 1150 1800 1450 
0 070 0 074 0 056 0 087 0 074 
1740 1310 1670 1910 1050 
0 027 0 021 0 026 0 029 0 017 
3370 3120 3540 4640 2980 
0 029 0 027 0 030 0 039 0 026 
1810 1630 1930 3130 957 
0 027 0 025 0 028 0 046 0 015 
1180 1470 1720 1380 2080 
0 093 0 118 0 132 0 106 0 168 
3330 1850 3220 5040 3120 
0 074 0 042 0 070 0 109 0 071 
1520 3030 1660 2330 2740 
0 016 0 032 0 017 0 024 0 029 
2740 3170 1770 1370 2110 
0 121 0 138 0 078 0 060 0 092 
4050 1460 2420 2110 2380 
0 061 0 021 0 036 0 031 0 035 
8820 5680 6800 5190 8010 
0 069 0 044 0 053 0 040 0 062 
7600 2310 3590 3030 3850 
0 099 0 030 0 046 0 039 0 049 
1700 1030 1390 2220 1270 
0 121 0 072 0 098 0 157 0 089 
4250 4090 3630 3200 2900 
0 094 0 089 0 080 0 071 0 063 
5800 3620 5390 5320 5750 
0 053 0 033 0 049 0 049 0 052 
1300 1590 989 1100 2810 
0 038 0 049 0 030 0 033 0 083 
1850 2650 3260 1950 2920 
0 026 0 023 0 028 0 017 0 024 
4100 3400 4060 3940 5570 
0 021 0 018 0 021 0 021 0 028 
2590 2800 5470 2720 3940 
0 021 0 023 0 044 0 022 0 031 
911 1450 1390 1460 1080 
0 035 0 059 0 055 0 058 0 042 
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0 021 0 034 0 050 0 030 0 031 
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0 013 0 020 0 022 0 024 0 029 
1590 1720 1460 1010 1290 
0 045 0 049 0 040 0 028 0 035 
2490 1320 1780 1630 3320 
0 022 0 012 0 016 0 014 0 029 
3780 3610 4290 3270 5070 
0 020 0 019 0 022 0 017 0 025 
2080 2780 2410 2500 5810 
0 017 0 023 0 020 0 021 0 046 
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0 032 0 039 0 063 0 055 0 040 
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Appendix 12 Method recovery results for tilapia, salmon and shrimp muscle including 
matrix matched recovery, internal standard corrected recovery and DMZ-D3 recovery. 
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X 100% 106% 115% 107% 95% 117% 104% 
SD 14% 10% 14% 14% 12% 13% 12% 
%RSD 14% 9% 12% 13% 12% 11% 11% 















































































































































































































































































































































































































































































x 104% 100% 115% 105% 92% 110% 99% 
SD 15% 11% 14% 13% 12% 16% 9% 
%RSD 14% 11% 12% 13% 14% 14% 9% 

















































































































































































































































































































































































































































































x 114% 107% 107% 107% 85% 108% 105% 
SD 21% 17% 14% 15% 13% 16% 16% 
%RSD 18% 16% 13% 14% 16% 15% 15% 
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Appendix 13 Method repeatability using uncorrected, spike corrected and internal standard corrected data for tilapia, salmon and 
shrimp muscle. Intermediate precision (analyst 1 and 2 combined results) is included for the uncorrected and spike corrected data. 
Tilapia muscle uncorrected data 


































































































































































































































































PRSD(R) 44.774 44.774 44.774 44.774 44.774 44.774 44.774 






































































































































































































Tilapia muscle uncorrected data 


































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 






































































































































































































Tilapia muscle uncorrected data 
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Tilapia muscle spike corrected data 


































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 








































































































































































































Tilapia muscle spike corrected data 


































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 








































































































































































































Tilapia muscle spike corrected data 
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Tilapia muscle IS corrected data 







































































































































































































































Tilapia muscle IS corrected data 








































































































































































































































Tilapia muscle IS corrected data 








































































































































































































































Salmon muscle uncorrected data 


































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 







































































































































































































Salmon muscle uncorrected data 


































































































































































































































































PRSD(R) 44 774 44 774 44 774 44.774 44.774 44.774 44.774 






































































































































































































Salmon muscle uncorrected data 
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Salmon muscle spike corrected data 
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Salmon muscle spike corrected data 
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Salmon muscle spike corrected data 
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Salmon muscle IS corrected data 







































































































































































































































Salmon muscle IS corrected data 








































































































































































































































Salmon muscle IS corrected data 








































































































































































































































Shrimp muscle uncorrected data 

































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 








































































































































































































Shrimp muscle uncorrected data 
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Shrimp muscle uncorrected data 
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Shrimp muscle spike corrected data 
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Shrimp muscle spike corrected data 

































































































































































































































































PRSD(R) 44 774 44 774 44 774 44 774 44 774 44 774 44 774 







































































































































































































Shrimp muscle spike corrected data 
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Shrimp muscle IS corrected data 







































































































































































































































Shrimp muscle IS corrected data 







































































































































































































































Shrimp muscle IS corrected data 







































































































































































































































Appendix 14 Raw data for CCP using uncorrected and spike corrected results for tilapia, salmon and shrimp muscle. 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix 16 Individual trout sample results from duplicate analyses during depletion study dosing and withdrawal periods. 































































































































































































































































































































































































































































































































































































































































































































































































































Furthest from the rest, but not a significant outlier 
(P>0.05) 
